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TSLP Regulates Intestinal Immunity and Inflammation
Abstract
This thesis characterizes and explores the role of thymic stromal lymphopoietin (TSLP) – TSLP receptor
(TSLPR) interactions in the regulation of intestinal immunity and inflammation. TSLP is known to promote
TH2 cytokine-mediated inflammation in the skin and the lung. Firstly, this thesis focuses on the
characterization of TSLP and TSLPR expression within the gastrointestinal (GI) tract and in the immune
cells of the associated lymphoid tissues. Our findings suggest that TSLP is primarily produced by
intestinal epithelial cells (IECs) under homeostatic conditions. Expression of the heterodimeric TSLPR
complex was exhibited on gut-associated lymphoid tissue (GALT) CD4+ T cells and CD11c+ dendritic
cells (DCs) as well as on splenic mast cells and basophils in naïve mice. Second, this thesis explores the
role of TSLP in the generation of a TH2 cytokine-mediated host-protective immune response to the
gastrointestinal helminth pathogen Trichuris muris. We demonstrate that in an intact animal TSLP-TSLPR
interactions are critical for resistance to Trichuris as disruption of the TSLP-TSLPR pathway either
through genetic deletion of the TSLPR, or antibody-mediated depletion of TSLP, resulted in susceptibility
to infection. Further, these mice exhibited increased infection-induced proinflammatory cytokine
production and inflammation. However, TSLP-TSLPR interactions were not required for the generation of a
host-protective TH2 cytokine-mediated immune response to Trichuris in the absence of IFN-γ, indicating
TSLP-independent intestinal TH2 immune responses. Third, we examine the potential for TSLP-TSLPR
interactions to regulate intestinal proinflammatory cytokine production. Examination of naïve TSLPR-/mice revealed a trend towards increased CD4+ T cell production of IFN-γ in the GALT compared to
TSLPR+/+ mice. Further, TSLPR-/- mice were more susceptible to DSS-induced colitis, exhibiting
increased proinflammatory cytokine production and more severe intestinal inflammation compared to
control mice. We demonstrate that TSLP can regulate DC-derived IL-12/23p40 production both in vitro
and in vivo and that rTSLP is able to inhibit CD4+ T cell production of IFN-γ in splenocyte cultures in the
absence of IL-4. Taken as a whole, this thesis identifies an important role for TSLP-TSLPR interactions in
regulating intestinal immunity and inflammation and in the maintenance of intestinal immune
homeostasis.
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Abstract

TSLP regulates intestinal immunity and inflammation
Betsy C. Taylor
David Artis

This thesis characterizes and explores the role of thymic stromal lymphopoietin (TSLP) –
TSLP receptor (TSLPR) interactions in the regulation of intestinal immunity and
inflammation. TSLP is known to promote TH2 cytokine-mediated inflammation in the skin
and the lung. Firstly, this thesis focuses on the characterization of TSLP and TSLPR
expression within the gastrointestinal (GI) tract and in the immune cells of the associated
lymphoid tissues. Our findings suggest that TSLP is primarily produced by intestinal
epithelial cells (IECs) under homeostatic conditions. Expression of the heterodimeric
TSLPR complex was exhibited on gut-associated lymphoid tissue (GALT) CD4+ T cells
and CD11c+ dendritic cells (DCs) as well as on splenic mast cells and basophils in naïve
mice. Second, this thesis explores the role of TSLP in the generation of a TH2 cytokinemediated host-protective immune response to the gastrointestinal helminth pathogen
Trichuris muris. We demonstrate that in an intact animal TSLP-TSLPR interactions are
critical for resistance to Trichuris as disruption of the TSLP-TSLPR pathway either
through genetic deletion of the TSLPR, or antibody-mediated depletion of TSLP, resulted
in susceptibility to infection. Further, these mice exhibited increased infection-induced
proinflammatory cytokine production and inflammation.

However, TSLP-TSLPR

interactions were not required for the generation of a host-protective TH2 cytokinemediated immune response to Trichuris in the absence of IFN-γ, indicating TSLPvii

independent intestinal TH2 immune responses.

Third, we examine the potential for

TSLP-TSLPR interactions to regulate intestinal proinflammatory cytokine production.
Examination of naïve TSLPR-/- mice revealed a trend towards increased CD4+ T cell
production of IFN-γ in the GALT compared to TSLPR+/+ mice. Further, TSLPR-/- mice
were more susceptible to DSS-induced colitis, exhibiting increased proinflammatory
cytokine production and more severe intestinal inflammation compared to control mice.
We demonstrate that TSLP can regulate DC-derived IL-12/23p40 production both in vitro
and in vivo and that rTSLP is able to inhibit CD4+ T cell production of IFN-γ in splenocyte
cultures in the absence of IL-4. Taken as a whole, this thesis identifies an important role
for TSLP-TSLPR interactions in regulating intestinal immunity and inflammation and in
the maintenance of intestinal immune homeostasis.
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Chapter 1: Literature Review
The intestinal immune system
Balancing immunity and inflammation in the intestine
The intestinal tract is the largest mucosal surface of the human body, with a surface area
of approximately 100-200 m2 (Mason 2008), and presents an immense immunologic
challenge to the host.

The large amount of exposed surface area is vulnerable to

invasion by pathogenic bacteria, viruses, fungi, and parasites. However, despite the
need to remain responsive against pathogenic microbes, the gastrointestinal (GI) tract
must also remain hyporesponsive to innocuous stimuli.

Due to its function in the

absorption of nutrients and minerals, the intestine is continually exposed to large
quantities of food and environmental antigens. Additionally, the adult human intestine is
colonized by an estimated 1014 “commensal” bacteria (Ley, Peterson et al. 2006; Frank
and Pace 2008), which exist in a mutualisitic relationship with the host. In fact, the
presence of commensal bacteria is required for normal development of the immune
system, and they play important roles in the supply of essential nutrients, the breakdown
of indigestible materials, and in the defense against opportunistic pathogens (Artis 2008;
Round and Mazmanian 2009). Loss of hyporesponsiveness to environmental, food, and
commensal-derived antigens leads to inflammation and disease states ranging from food
allergy to inflammatory bowel disease (IBD) (Bouma and Strober 2003; Macdonald and
Monteleone 2005; Karin, Lawrence et al. 2006).

In order to contend with these diverse challenges, the intestinal immune system has
developed a complex combination of both anatomic and immunological adaptations that
help maintain host immune homeostasis. One of the most important anatomic features
1

of the intestine is the separation of the external environment from the sterile tissues of
the body by a single layer of intestinal epithelial cells.

Intestinal epithelial cells (IECs) form a physical barrier
IECs have developed numerous adaptations that allow them to physically separate the
contents of the lumen of the gut from the cells of the lamina propria. The apical surface
of IECs is covered in microvilli, a dense network of actin filaments and membrane
invaginations that combine to form the brush border.

The brush border not only

increases the surface area of the cell allowing maximal absorption of nutrients, but also
serves to separate luminal contents from the main IEC cell body (Sansonetti 2004).
Additionally, IECs are directly interconnected through a series transmembrane proteins
including claudins that form tight junctions. Tight junctions prevent the translocation of
bacteria between cells and are actively regulated to allow selective permeability of the
barrier (Sansonetti 2004). The cellular barrier is also reinforced chemically, as goblet
cell-derived mucins bind the apical surface of IECs to form a glycocalyx, and further
mucin production results in a thick layer of mucus that acts as a semi-permeable barrier
that traps bacteria and sequesters them away from direct contact with IECs (Sansonetti
2004). IECs also possess antimicrobial properties: they secrete defensins, cathelicidins,
and calprotectins whose amphipathic nature allows for insertion into and disruption of
bacterial cell walls (Ganz 2003; Salzman, Ghosh et al. 2003; Agerberth and
Gudmundsson 2006).

IEC production of antimicrobial products helps to control and

regulate bacterial growth, while also helping to prevent live bacteria from directly
contacting IECs.

Together, these IEC adaptations combine to make a substantial

2

physical barrier separating potentially pathogenic external stimuli from the lamina propria
and are critical in the maintenance of intestinal immune homeostasis.

IECs actively modulate intestinal immune responses
In addition to providing a physical barrier, IECs also actively respond to and interact with
their environment.

IECs are known to express a wide variety of pattern-recognition

receptors including members of the Toll-like receptor (TLR) family and the nucleotidebinding oligomerization domain (NOD)-like receptors (NLRs) (Artis 2008; Gribar,
Richardson et al. 2008), which have been demonstrated to be important in the
maintenance of intestinal immune homeostasis (Rakoff-Nahoum, Paglino et al. 2004).
Importantly, IECs can discriminate between commensal and pathogenic organisms,
helping to maintain the balance between immunity and inflammation.

Possible

mechanisms that allow for the selective activation of IECs by pathogenic bacteria
compared to commensal bacteria include the selective and regulated expression of
TLRs and NLRs, apical versus basolateral expression of TLRs, and the modulation of
IEC signaling pathways by commensal bacteria (Neish, Gewirtz et al. 2000; Kelly,
Campbell et al. 2004; Artis 2008).

When infected by enteropathogenic bacteria, IECs maintain the ability to respond and
upregulate a diverse array of immune response genes.

Activation results in the

induction of cytokines including IL-8 and TNF-α as well as the expression of chemokines
such as CCL2 (Eckmann, Kagnoff et al. 1993; Jung, Eckmann et al. 1995; Yang,
Eckmann et al. 1997). These factors act to activate resident immune cells and to recruit
monocytes to the site of infection, thus initiating the immune response. IEC recognition

3

of pathogenic bacteria is important in the initiation of protective immune responses.
Deletion of the pattern recognition receptors TLR4 or NOD1 or the central TLR signaling
molecule MyD88 in non-haematopoietic cells resulted in impaired immunity following
bacterial infection (Schilling, Martin et al. 2003; Brandl, Plitas et al. 2007; Lebeis,
Bommarius et al. 2007). The NF-κB signaling pathway appears to be a central regulator
in IEC activation as multiple types of enteroinvasive bacteria activate the pathway and
induce nuclear localization and DNA binding of NF-κB in IECs (Elewaut, DiDonato et al.
1999).

In addition to responding to bacterial invasion, IEC-intrinsic NF-κB signaling is critical to
maintaining intestinal immune homeostasis. Mice with an IEC-specific deletion of IKK-γ
(also known as NEMO), a critical regulator protein of the NF-κB pathway that is essential
to both classical and non-classical NF-κB signaling, develop spontaneous colitis (Nenci,
Becker et al. 2007). Loss of NEMO within IECs results in impaired IEC barrier function,
with increased colonic IEC apoptosis, decreased antimicrobial peptide production, and
translocation of bacteria into the lamina propria. Conditional ablation of either IKK-β or
IKK-α specifically in IECs did not result in the development of spontaneous colitis in
mice, indicating that suboptimal NF-κB signaling is sufficient to maintain barrier integrity
(Nenci, Becker et al. 2007).

However, when challenged with the intestinal helminth

pathogen Trichruis muris, mice specifically lacking IKK-β in IECs exhibited increased
susceptibility, increased proinflammatory cytokine production, and severe infectioninduced inflammation compared to littermate control mice (Zaph, Troy et al. 2007).
These results implicate the NF-κB pathway as a central regulator of intestinal immune

4

homeostasis and in the development of host-protective immune responses to a broad
spectrum of intestinal pathogens.

IECs modulate downstream responses through the regulated secretion of a number of
immunomodulatory factors including IL-10, prostaglandin E2 (PGE2), transforming growth
factor-β (TGF-β), and thymic stromal lymphopoietin (TSLP).

IECs have been

demonstrated to produce the anti-inflammatory cytokine IL-10 constitutively (Jarry,
Bossard et al. 2008), which can inhibit proinflammatory cytokine production from
macrophages and dendritic cells (DCs) (Mosser and Zhang 2008). PGE2 inhibits DC
production of IL-12 if present during priming, favoring the differentiation of naïve CD4+ T
cells into TH2 cells. Further, PGE2 can act directly on CD4+ T cells to down modulate
their production of IFN-γ (Harris, Padilla et al. 2002). IECs constitutively secrete large
amounts

of

TGF-β

(Barnard,

Warwick

et

al.

1993),

which

potently

inhibits

proinflammatory cytokine production from macrophages and DCs and plays a role in the
differentiation of both regulatory T cells and TH17 cells (Rubtsov and Rudensky 2007).
IECs also express TSLP, a cytokine implicated in the maintenance of intestinal immune
homeostasis through its modulation of DC function (Rimoldi, Chieppa et al. 2005). This
thesis will investigate the role of TSLP in the intestinal immune system.

Thymic stromal lymphopoietin (TSLP)
Cellular sources and regulation of TSLP
While TSLP was initially identified and characterized as a novel cytokine produced by
thymic stromal cells (Friend, Hosier et al. 1994; Sims, Williams et al. 2000; Quentmeier,
Drexler et al. 2001), it is predominantly expressed in epithelial cells of the skin
5

(keratinocytes), lung (small airway epithelial cells), and intestine (IECs) (Sims, Williams
et al. 2000; Reche, Soumelis et al. 2001; Soumelis, Reche et al. 2002; Liu, Soumelis et
al. 2007). Basal expression of TSLP mRNA in the steady state has been detected in
epithelial cells of the tonsils, skin, lung, and intestine (Soumelis, Reche et al. 2002; Liu,
Soumelis et al. 2007; Zaph, Troy et al. 2007); however, the basal production of TSLP
protein has only been found in the lung, tonsils, and intestine (Watanabe, Hanabuchi et
al. 2004; Rimoldi, Chieppa et al. 2005; Zhang, Shan et al. 2007). Structurally, TSLP
resembles IL-7 and is a four-helix bundle cytokine. There is no cross-species reactivity
between human and murine TSLP; they exhibit only 43% amino acid sequence identity
(Liu, Soumelis et al. 2007). However, despite these substantial molecular differences,
human and murine TSLP exert similar biological functions.

Increased TSLP expression in epithelial cells can be induced through exposure to viral,
bacterial, or parasitic pathogens as well as ligation of Toll-like receptors (TLRs)
(Allakhverdi, Comeau et al. 2007; Kato, Favoreto et al. 2007; Humphreys, Xu et al. 2008;
Zeuthen, Fink et al. 2008; Kinoshita, Takai et al. 2009; Ramalingam, Pesce et al. 2009).
Treatment with extract from the common environmental fungus, Alternaria alternata,
resulted in TSLP induction in airway epithelial cells (Kouzaki, O'Grady et al. 2009),
indicating allergen-driven TSLP expression.

Exposure to proinflammatory cytokines

such as IL-1β and TNF-α, or to TH2 cell-associated cytokines IL-4 and IL-13 alone or in
combination has also been shown to induce the expression of TSLP (Bogiatzi,
Fernandez et al. 2007; Kato, Favoreto et al. 2007; Lee and Ziegler 2007; Zhang, Shan et
al. 2007; Miyata, Nakamura et al. 2009; Tanaka, Saga et al. 2009).

Interestingly,

administration of IL-13 was able to induce STAT6-dependent TSLP production in murine
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epithelial cells from nasal, tracheal, lung, and skin explants, but not from the intestine
(Miyata, Nakamura et al. 2009), indicating the possibility that tissue-specific regulatory
mechanisms may exist.

In addition to IL-13, treatment of a lung epithelial cell line,

MLE12, with IL-25, another cytokine associated with the promotion of TH2 cytokinedependent immune responses, resulted in increased TSLP expression (Angkasekwinai,
Park et al. 2007). Further, treatment with the TH2-associated cytokine IL-33 increased
TSLP mRNA expression in cecal tissues of mice infected with Trichuris muris
(Humphreys, Xu et al. 2008).

Examination of the promoter regions for both human and murine TSLP revealed an NFκB-binding site that is responsible for increased TSLP expression following exposure to
IL-1β and TNF-α (Lee and Ziegler 2007).

Recent studies focusing on keratinocyte

biology have found that epidermal kallikrein (KLK5), a serine protease, upregulates
TSLP expression in human keratinocytes through the activation of proteinase-activated
receptor 2 (PAR2) in a NF-κB-dependent manner (Briot, Deraison et al. 2009). PAR2
was additionally shown to be important since siRNA-mediated knockdown of PAR2
expression inhibited TSLP production in response to both the allergen-derived cysteine
protease papain and the prototypic protease trypsin in airway epithelial cells (Kouzaki,
O'Grady et al. 2009)

However, papain-induced TSLP expression was not entirely

dependent upon PAR2, indicating the presence of additional mechanisms (Kouzaki,
O'Grady et al. 2009). Consistent with a role for allergens in the induction of TSLP, both
TSLP mRNA and protein were found to be dynamically upregulated in the dermis of
atopic patients during allergen-induced late phase cutaneous responses (Corrigan,
Jayaratnam et al. 2009). Clinical studies examining genetic variants of the tslp gene in
7

bronchial epithelial cells from 36 patients identified a single nucleotide polymorphism
(SNP) in the promoter region of the long-form tslp that enhanced binding of the
transcription factor activating protein (AP)-1 and increased promoter-reporter activity in
response to stimulation (Harada, Hirota et al. 2009). These findings implicate for the first
time a role for genetic polymorphisms in the regulation of TSLP expression.

There is speculation that TSLP can influence wound healing as expression can be
upregulated by damage or trauma to epithelial cells (Allakhverdi, Comeau et al. 2007)
(Figure 1).

Also, TSLP treatment of human nasal epithelial cells in vitro resulted in

enhanced barrier function and increased expression of the tight-junction proteins claudin
-1, -4, -7, and occludin (Kamekura, Kojima et al. 2009). Further, studies examining the
link between cigarette smoking and asthma have found that intranasal administration of
cigarette smoke extract to mice upregulates TSLP mRNA and protein in the lung in an
oxidative-stress dependent manner (Nakamura, Miyata et al. 2008).

Also, clinical

studies utilizing both bronchial biopsies and bronchoalveolar lavage (BAL) fluid samples
found significantly elevated levels of TSLP mRNA positive cells and protein in patients
with asthma or chronic obstructive pulmonary disease (COPD) compared to healthy,
never-smoking controls (Ying, O'Connor et al. 2008). Although the molecular mediators
and mechanisms of action remain unknown, recent work suggests that mast cells may
also induce TSLP expression in epithelial cells, as mast cell-deficient mice fail to
upregulate TSLP in a model of allergic rhinitis (Miyata, Hatsushika et al. 2008). These
findings indicate a role for communication between immune cells and epithelial cells in
the induction of TSLP expression.
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In addition to microbial-derived signals, host-derived cytokines, and cell damage, nuclear
receptors may also play a role in the regulation of TSLP.

Ablation of retinoid X receptor

in keratinocytes induced increased TSLP expression in these cells (Li, Messaddeq et al.
2005).

Supporting this, treatment of normal keratinocytes with the nuclear receptor

agonist vitamin D3 or low-calcemic analogs elevated TSLP production (Li, Hener et al.
2006). A summary of factors known to induce TSLP expression is depicted in Figure 1
and included in Table 1.

While the majority of studies to date have focused on the identification of factors known
to induce TSLP production in epithelial cells, several factors have been identified that
may be able to negatively regulate TSLP expression. Treatment of airway epithelial
cells or primary human keratinocytes with glucocorticoids was sufficient to inhibit
dsRNA-induced TSLP expression (Le, Takai et al. 2009; Miyata, Nakamura et al. 2009).
Interestingly, topical administration of glucocorticoids is commonly used to treat patients
with atopic dermatitis (Norris 2005), suggesting that one potential mechanism of action
of the drug is the inhibition of TSLP production. Also, one study has recently proposed
that 9-cis-retinoic acid may act to negatively regulate TSLP expression in airway
epithelial cells (Lee, Headley et al. 2008). Given the findings that TSLP can be induced
by both exogenous stimuli (damage, infection, TLR ligation) and host-derived signals,
TSLP production by epithelial cells and its regulation may represent a critical pathway
through which epithelial cells and the immune system communicate (Figure 1).

Although the current literature indicates that epithelial cells are a dominant source of
TSLP, reports have identified hematopoietic cell-derived TSLP as mast cells and
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basophils have been shown to express TSLP following stimulation. Mast cells were first
identified as a possible source of TSLP when TSLP mRNA expression was examined in
cDNA libraries from different primary cells. In contrast to constitutive production of TSLP
by IECs, TSLP expression in mast cells requires stimulation, as cross-linking of the IgE
receptor on mast cells results in elevated levels of TSLP mRNA (Soumelis, Reche et al.
2002). More recent data suggest that mast cell production of TSLP may be specific to
IgE cross-linking, as treatment of mast cells with LPS, polyI:C , and IL-4 failed to induce
TSLP mRNA expression. However, preincubation with IL-4 prior to IgE cross-linking
significantly increased mast cell TSLP expression (Okayama, Okumura et al. 2009).
Examination of suppressor of cytokine signaling 7 (SOCS7) in mast cells revealed a
novel regulatory role for SOCS7 in the inhibition of TSLP production, as bone marrowderived mast cells from Socs7 deficient mice exhibit increased production of TSLP
compared to wild type (WT) controls following FcεRI-mediated activation (Knisz, Banks
et al. 2009). Similar to mast cells, basophils do not appear to express TSLP in a resting
state. However, basophils stimulated with papain upregulate both TSLP mRNA and
protein (Sokol, Barton et al. 2008). While mast cells and basophils make TSLP in vitro,
the contribution of these cellular sources in vivo remains to be fully ascertained.
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Figure 1 Regulation of TSLP production

Figure 1 Epithelial cells are a source of TSLP. TSLP expression is induced
following exposure to both external and host-derived stimuli. Modified from Saenz,
Taylor et al. 2008
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Cellular targets of TSLP
TSLP-TSLPR signaling
High affinity ligand binding of TSLP and subsequent signaling requires a heterodimeric
receptor consisting of the IL-7Rα chain (CD127) and a unique TSLPR-α chain that
resembles the common cytokine receptor γ chain (γc) (Park, Martin et al. 2000; Reche,
Soumelis et al. 2001). Despite poor sequence homology between human and mouse
TSLPR, both activate similar signaling pathways.

Ligation of TSLPR leads to the

downstream phosphorylation and activation of signal transducer and activator of
transcription (STAT) 5 and STAT3 in mice, and STAT5 in humans (Isaksen, Baumann et
al. 1999; Levin, Koelling et al. 1999; Sebastian, Borowski et al. 2008). TSLP-mediated
STAT5 activation appears to be independent of any of the four Janus kinases (JAKs),
however, partial abrogation of TSLP-mediated STAT5 phosphorylation was observed in
cells expressing a dominant negative form of Tec kinase, indicating possible Tec family
kinase involvement in TSLP signaling (Isaksen, Baumann et al. 1999; Levin, Koelling et
al. 1999; Reche, Soumelis et al. 2001; Liu, Soumelis et al. 2007) (Figure 2).

Also,

studies indicate that TSLP signaling does not result in the activation of either ERK1/2 or
p70S6K (Quentmeier, Drexler et al. 2001).

These findings suggest that neither the

mitogen-activated protein kinase (MAPK) pathway nor the p70S6K pathway are involved
in TSLP-elicited signal transduction. The specific involvement of tyrosine kinases, their
association with TSLPR, and the subsequent gene targets of TSLP-TSLPR interactions
remain poorly defined (Figure 2).

Initially, based on mRNA and TSLP responsiveness, TSLPR expression was thought to
be limited to immature B cells and myeloid cells such as monocytes and DCs (Park,
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Martin et al. 2000; Reche, Soumelis et al. 2001; Liu, Soumelis et al. 2007). However,
more recent work has highlighted a wider pattern of TSLPR expression as mast cells
and human and murine CD4+ T cells are responsive to treatment with TSLP alone, or in
conjunction with other cytokines (Allakhverdi, Smith et al. 2007; Omori and Ziegler 2007;
Rochman, Watanabe et al. 2007; Sokol, Barton et al. 2008; Lu, Wang et al. 2009) (Table
1). DCs and mast cells appear to express TSLPR constitutively (Reche, Soumelis et al.
2001; Soumelis, Reche et al. 2002; Allakhverdi, Comeau et al. 2007), however CD4+ T
cells appear to require TCR stimulation to induce receptor expression and become
sensitive to TSLP treatment (Al-Shami, Spolski et al. 2004; Omori and Ziegler 2007;
Rochman, Watanabe et al. 2007; Lu, Wang et al. 2009). As high affinity ligand binding is
dependent upon the dimerization of the TSLPR-α chain with the IL-7R-α chain, coexpression of CD127 must also be examined. While lymphoid cell expression of CD127
has been well documented and studied (Mazzucchelli and Durum 2007), DC expression
of CD127 remains more controversial with findings varying between tissue, DC subset,
and activation status (Guimond, Veenstra et al. 2009; Vogt, Link et al. 2009). The recent
development of a fluorochrome-conjugated TSLPR-α chain-specific mAb for flow
cytometry has allowed for the investigation of TSLPR complex expression on a variety of
cell types directly ex vivo. Analysis of TSLPR complex expression on cells in the GALT
will be presented in Chapter 2.

Initial reports characterizing the function of TSLP on myeloid cell populations
demonstrated that human monocytes and CD11c+ DCs were sensitive to TSLP
treatment in vitro and were potently stimulated to produce CCL17, a known ligand for
CCR4, which is expressed on polarized TH2 cells (Reche, Soumelis et al. 2001).
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Further, TSLP enhanced the spontaneous maturation of blood-derived human CD11c+
cells, increasing their expression of co-stimulatory molecules and their ability to promote
naïve CD4+ T cell proliferation (Reche, Soumelis et al. 2001). The putative link between
TSLP and TH2 cytokine responses was solidified when TSLP-treated DCs were
demonstrated to drive IL-4, IL-5, and IL-13 production from naïve CD4+ T cells upon coculture (Soumelis, Reche et al. 2002).

Mechanistic analysis demonstrated that TSLP-treatment of DCs induced multiple
changes in DC function to create a permissive environment for TH2 cell differentiation.
TSLP-treatment of human monocyte-derived DCs (mDCs) was shown to alter DC
maturation such that the ability to upregulate major histocompatibility complex (MHC)
class II and the co-stimulatory molecules CD80 and CD86 was preserved while DC
cytokine production was selectively altered, thus resulting in the ability to stimulate and
influence T cell differentiation (Soumelis, Reche et al. 2002; Rimoldi, Chieppa et al.
2005). TSLP-treated mDCs do not produce IL-12 and TSLP treatment of either mDCs or
murine bone marrow-derived DCs (BMDCs) results in the inhibition of IL-12 production
following stimulation with TLR-ligands or whole bacteria (Rimoldi, Chieppa et al. 2005;
Zaph, Troy et al. 2007). TSLP-treatment also induces the expression of OX40L, which
promotes TH2 cell differentiation in the absence of IL-12 (Ito, Wang et al. 2005). The
presence of OX40L on TSLP-treated DCs also induces production of TNF-α in TH2 cells
(instead of IL-10), suggesting these cells may have altered functions compared to
conventional TH2 polarized cells (Ito, Wang et al. 2005; Liu 2006; Liu 2007).
Interestingly, treatment of human DCs activated by TSLP with the imidazoquinoline
compound R848 was sufficient to revert the DCs to induce TH1 cell differentiation. The
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TH1 cell-inducing capacity of the R848 treated TSLP-DCs was dependent upon the
induction of IL-12 expression and the repression of OX40L (Torii, Ito et al. 2008), thus
highlighting the opposing roles of IL-12 and OX40L in TSLP-induced DC function.
Additionally, the reversibility of the effects of TSLP on DCs upon R848 treatment
suggests plasticity and that TSLP may not represent an overriding signal on DCs for T
cell differentiation.

The capacity of TSLP to modulate DC and T cell-derived

proinflammatory cytokines will be examined in Chapter 4.

The ability of TSLP to promote TH2 cytokine responses is not confined to its abilities to
influence DC function, as it is also able act on mast cells and T cells. Human mast cells
have been recently demonstrated to express the functional TSLPR complex, and
following exposure to TSLP they produce the TH2 cytokines IL-5 and IL-13 as well as the
proinflammatory cytokines IL-6 and GM-CSF (Allakhverdi, Comeau et al. 2007).
However, it is important to note that mast cells were unable to respond to TSLP alone
and required IL-1 or TNF-α to induce cytokine expression (Allakhverdi, Smith et al. 2007)
suggesting that a proinflammatory environment must be present for mast cells to be
responsive to TSLP. Similarly, exposure to IL-33 is also able to sensitize mast cells to
TSLP stimulation, resulting in mast cell production of IL-5, IL-13, GM-CSF, and
enhanced production of several chemokines (Allakhverdi, Smith et al. 2007).

However,

IL-1, TNF-α, or IL-33 in conjunction with TSLP did not result in mast cell degranulation or
mediator release (Allakhverdi, Comeau et al. 2007; Allakhverdi, Smith et al. 2007).
TSLP, in conjunction with either IL-1/TNF-α or IL-33, is also able to act upon CD34+
haematopoietic progenitor cells to induce IL-5 and IL-13 production (Allakhverdi,
Comeau et al. 2009). The ability of TSLP to influence CD34+ progenitor cells, which are
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released from the bone marrow and following circulation into peripheral tissues
differentiate into mast cells, eosinophils, or basophils indicates that TSLP may act on
innate cells at multiple time points during TH2 cytokine-mediated inflammation.

In vitro studies demonstrated that following TCR stimulation human CD4+ T cells
upregulate TSLPR expression and become sensitive to TSLP (Rochman, Watanabe et
al. 2007; Lu, Wang et al. 2009). TSLP treatment of stimulated murine CD4+ T cells in
vitro also results in the expression of IL-4 (Omori and Ziegler 2007). Collectively, these
reports identify several cellular targets for TSLP in vivo and provide multiple
mechanisms for TSLP to influence both innate and adaptive immune responses.
summary of known cellular targets in presented in Table 1.
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A

Figure 2 TSLPR signaling pathways

Figure 2 Downstream signaling pathways activated following TSLP receptor
ligation. Modified from Saenz, Taylor et al. 2008
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Table 1 Summary of cellular sources, stimuli that induce expression, and cellular
targets of TSLP

Cellular
sources

Thymic stromal cells
Lung ECs
Tonsilular crypt EC
Intestinal ECs
Keratinocytes
Mast cells
Basophils

Inducing
stimuli
TLR ligands
Viruses
Bacteria
Helminth parasites
Environmental airborne fungi
IL-1, TNF-α
IL-4, IL-13
IL-25
IL-33
Tissue damage
FcE cross linking
Papain
Trypsin
Epidermal kallikrein (KLK5)
Cigarette smoke extract
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Target cell
populations

Monocytes
Dendritic cells
CD4+ T cells
CD8+ T cells
Mast cells
B cells

Role of TSLP in immune system development
Initially described as a factor able to support and promote the development of the
NAG8/7 B cell line in vitro, TSLP was characterized as a B lymphocyte growth factor
(Friend, Hosier et al. 1994; Sims, Williams et al. 2000). Subsequent in vitro studies
demonstrated that B cell precursors must differentiate to the large pre-B stage and
express the pre-B cell receptor in order to respond to TSLP treatment (Vosshenrich,
Cumano et al. 2003; Vosshenrich, Cumano et al. 2004).

However, in vivo studies

utilizing TSLPR-/- mice demonstrated no role for the TSLP pathway in B lymphopoiesis.
TSLPR-/- mice were indistinguishable from littermate control animals and had normal
populations of B cells in adult animals (Carpino, Thierfelder et al. 2004).

Despite

unaltered B cell development in the absence of TSLP responsiveness, systemic
overexpression of TSLP in vivo results in altered composition and frequency of B cell
populations (Taneda, Segerer et al. 2001; Osborn, Ryan et al. 2004; Astrakhan, Omori
et al. 2007).

For example, targeted overexpression of TSLP in the skin increased

circulating levels of TSLP that resulted in enhanced numbers of immature and naïve B
cells in the periphery, loss of splenic marginal zone B cells, and increased numbers of
peritoneal B-1b B cells (Astrakhan, Omori et al. 2007). B cell development was also
impacted in a TSLP-dependent manner in a study examining the importance of Notch
signaling in maintaining epidermal integrity in mice. Demehri et al. demonstrated that
successive loss of Notch signaling specifically in the epidermis results in increased
serum levels of TSLP, and that the increase in TSLP production was responsible for the
lethal B-lymphoproliferative disorder observed in these mice (Demehri, Liu et al. 2008).
While there was no evidence suggesting direct regulation of TSLP by Notch in epithelial
cells, the authors link the heightened TSLP production to the inability to form fully
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differentiated keratinocytes capable of barrier formation (Demehri, Liu et al. 2008).
Similar to the skin transgenic model, the mice with heightened TSLP exhibited greatly
expanded pre- and immature B cell compartments in the periphery (Demehri, Liu et al.
2008).

Taken together, these data suggest that while TSLP is dispensable for B

lymphopoiesis under normal conditions, excess production of TSLP can influence B cell
development in vivo.

Despite the similarity of TSLP to IL-7 and the TSLPR chain to the γc, the TSLP-TSLPR
pathway does not seem to be strictly required for T cell development.

Examination of

TSLPR-/- mice revealed normal T cell lymphopoiesis and normal T cell populations in
adult mice (Carpino, Thierfelder et al. 2004). However, increased lymphoid defects seen
in γc/TSLPR double deficient over γc single deficient mice and the ability of transgenically
overexpressed TSLP to restore lymphoid development in IL-7 deficient mice indicate that
TSLP maintains the ability to support or promote T cell lymphopoiesis (Al-Shami, Spolski
et al. 2004; Chappaz, Flueck et al. 2007). In vitro, TSLP was demonstrated to increase
thymopoiesis in murine fetal thymic organ culture (Jiang, Coffield et al. 2007). Further,
TSLP appears to influence the proliferative capacity of CD4+ T cells, as addition of TSLP
to TCR stimulated CD4+ T cells in vitro resulted in increased cell division (Al-Shami,
Spolski et al. 2004).

TSLP acting on DCs may also play a role in CD4+ T cell

homeostasis as TSLP-treated DCs stimulated increased expansion of autologous CD4+
T cells compared to control DCs (Watanabe, Hanabuchi et al. 2004). Additionally, CD4+
T cells from TSLPR-/- mice expand less efficiently than WT CD4+ T cells in irradiated
hosts (Al-Shami, Spolski et al. 2004). Thus, similar to B cell development, TSLP is not
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critical for T lymphopoiesis under normal conditions but alterations in its availability may
impact T cell development or optimize T cell expansion under certain circumstances.

Thymic expression of TSLP has been demonstrated to function in DC activation and
regulatory T cell (Treg) development. Expression of TSLP within the epithelial cells of
the Hassal’s corpuscles region of the human thymic medulla correlates with DC
activation and the subsequent positive selection of high-affinity self-reactive Tregs
(Watanabe, Wang et al. 2005). Although mice lack the Hassal’s corpuscle structure
within the thymus, there is evidence to support a potential role for murine TSLP in the
direct promotion of Treg development.

Supplementation of TSLP within fetal thymic

organ cultures increased expression of FoxP3 and culture of thymocytes with TSLP
promoted the differentiation of CD4+CD25+FoxP3+ cells (Jiang, Su et al. 2006; Lee, Lim
et al. 2008). Depletion of IL-7 in the presence or absence of TSLPR was shown to
produce a more severe defect in Treg development in the thymus when mice were
lacking both IL-7 and TSLPR (Mazzucchelli, Hixon et al. 2008). These results suggest
that TSLP and IL-7 may have some redundant and/or overlapping function in thymic
Treg development.

In addition to influencing thymic Treg development, TSLP has also been proposed to
influence peripheral conversion of naïve CD4+ T cells to FoxP3+ Treg cells. Studies
found that TSLP-treated DCs co-cultured in vitro with total splenic CD4+ T cells
increased the frequency of CD4+CD25+FoxP3+ T cells compared to either unstimulated
or LPS-stimulated DCs (Besin, Gaudreau et al. 2008).
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Further, in vitro work using

human epithelial cells indicate that IEC-derived TSLP may be important for optimal
peripheral conversion of CD4+ T cells into FoxP3+ Tregs (Iliev, Spadoni et al. 2009).

Despite these findings, the relative importance of TSLP influencing either natural or
adaptive Treg populations in vivo remains controversial. Examination of TSLPR-/- mice
found normal numbers of circulating CD4+CD25+FoxP3+ Tregs (Sun, Hall et al. 2007),
indicating that TSLP is not essential for the development of natural Tregs. Additionally,
analysis of surface marker expression on developing CD4+FoxP3+ Tregs in the thymus
failed to show TSLPR-α chain expression, and these cells did not phosphorylate STAT-5
in response to TSLP stimulation (Vang, Yang et al. 2008). Further, lamina propria DCs
isolated from TSLPR-/- mice did not exhibit any defect in mediating FoxP3 Treg
conversion in vitro (Sun, Hall et al. 2007), suggesting that TSLP is also not required for
adaptive Treg development in the periphery.

Studies focusing on mature Treg cell

survival in the periphery also failed to define a role for peripheral Treg homeostasis
(Mazzucchelli, Hixon et al. 2008). Taken as a whole, these finding suggest that TSLP is
not essential for B or T cell lymphopoiesis or the development/selection/maintenance of
CD4+FoxP3+ Tregs in vivo. However, TSLP may be able to modulate these processes in
cases of increased or altered availability.
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Functional biology of TSLP in the skin and lung
TSLP was first associated with dysregulated TH2 cytokine production in the human
disease of atopic dermatitis. Skin biopsies from atopic dermatitis lesions showed greatly
enhanced levels of TSLP compared to non-lesion biopsies (Soumelis, Reche et al.
2002).

Heightened TSLP expression was also detected in the airways of asthmatic

patients and correlated with disease severity (Ying, O'Connor et al. 2005).

A more

causal relationship between TSLP and TH2 cytokine-mediated disease was established
with transgenic over-expression models. Targeted overexpression of TSLP in epithelial
cells of the skin or lung results in the development of severe TH2-cytokine mediated
inflammation resembling atopic dermatitis and asthma, respectively (Li, Messaddeq et
al. 2005; Yoo, Omori et al. 2005; Zhou, Comeau et al. 2005).

In both tissues, the

increased expression of TSLP resulted in the development of CD4+ TH2 cells,
inflammatory cell infiltration, eosinophil infiltration, increased IgE production, and tissue
damage.

The CD4+ TH2 cells that developed were highly polarized, producing high

levels of IL-4 with little to no IFN-γ production being detected (Li, Messaddeq et al. 2005;
Yoo, Omori et al. 2005; Zhou, Comeau et al. 2005).

The link between increased TSLP expression and disease has also been strengthened
by the phenotype of transgenic mice whose gene alterations lead to the dysregulated
overproduction of TSLP.

Mice lacking nuclear hormone receptor retinoid X receptor

(RXR) isotypes RXR-α and RXR-β expression specifically in keratinocytes have
significantly increased production of TSLP and develop a TH2 cytokine-mediated chronic
dermatitis that mirrors human atopic dermatitis (Li, Messaddeq et al. 2005). Further,
application of topical vitamin D3 and other agonists for the RXR-α and RXR-β signaling
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pathways lead to increased TSLP expression and in turn severe chronic dermatitis (Li,
Hener et al. 2006).

Consistent with the connection between dysregulated TSLP

production and atopic disease, mice lacking responsiveness to TSLP (TSLPR-/-) mice
are less susceptible to an OVA-induced model of allergic asthma. In this model, TSLPR/-

animals failed to produce TH2 cell-associated cytokines and did not exhibit lung

inflammation (Al-Shami, Spolski et al. 2005; Zhou, Comeau et al. 2005).

The expression of TSLP is largely restricted to barrier surfaces and it has been proposed
that TSLP acts primarily in the microenvironment surrounding its site of production.
While tissue-specific overexpression of TSLP in the lung resulted in increased levels of
circulating total IgE, for example, the inflammatory response was predominately
restricted to the lung. Activated, cytokine producing CD4+ T cells isolated from this site
expressed the skin/lung homing marker CCR4.

Furthermore, while CD4+ IL-4+ cells

were detectable in the lung and draining lymph nodes, few cytokine positive cells were
detected in peripheral lymph nodes (Zhou, Comeau et al. 2005).

While TSLP appears to primarily act within its localized microenvironment under
physiological conditions, heightened systemic levels of TSLP have been demonstrated
to alter systemic immune responses. For instance, examination of the K5-TSLP or K14TSLP transgenic mice, which despite being under keratinocyte-specific promoters have
overproduction of TSLP with high levels of circulating TSLP detected in the serum
(Astrakhan, Omori et al. 2007; Chappaz, Flueck et al. 2007), revealed altered systemic
immune responses. These mice display increased serum levels of IL-5 and elevated
numbers of circulating eosinophils (Li, Messaddeq et al. 2005), as well the presence of
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IL-4-producing CD4+ T cells in non-skin draining lymph nodes (Zhou, Comeau et al.
2005).

Further, repeated intradermal injection of recombinant TSLP into WT mice

induces increased levels of serum IgE and IgG1 (Jessup, Brewer et al. 2008).
Additionally,

studies

investigating the

link

between

atopic

dermatis

and

the

predisposition to the development of asthma (also known as the “atopic march”) have
found that keratinocyte-derived systemic levels of TSLP increased the severity and
onset of experimental asthma (Demehri, Morimoto et al. 2009; Zhang, Hener et al.
2009).

Taken together, these findings suggest that increased production of TSLP

extends its influence beyond barrier surfaces and may lead to predisposition of the host
to multiple TH2 cytokine-mediated pathologies.

Given the ability of TSLP to influence DC responses in vitro, TSLP may target DCs to
modulate localized immune responses. Either skin or lung resident DCs could become
conditioned or activated by locally produced TSLP, migrate to the draining lymph node,
initiate TH2 cell differentiation, and imprint on the T cells the proper receptors to return to
sites of inflammation. The expression of TSLPR on activated CD4+ T cells also raises
the possibility that TSLP could act directly on infiltrating CD4+ T cells to promote TH2 cell
development. These possibilities are not mutually exclusive, however, and the ability of
DCs to produce the TH2 cell attracting chemokines, CCL17 and CCL22, may also act to
help initiate and/or promote local TH2 cytokine responses. However, as DC responses in
vivo have not been examined directly in any of the existing literature and cell-specific
TSLPR-/- mice have not been reported, it remains uncertain as to which cells TSLP is
acting on in vivo to initiate TH2-cytokine mediated inflammation.
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Although it remains unclear which cells TSLP targets in vivo during allergic responses,
evidence exists to suggest that an innate cell component is also involved. In the K5TSLP skin transgenic model, the contribution of T cells to the inflammatory phenotype
was determined by generating K5-TSLP transgenic mice that were also T cell deficient.
In the absence of T cells, immune pathology still developed and inflammatory cell
infiltration was observed (Yoo, Omori et al. 2005). Also, RAG-/- mice treated on the ear
with the vitamin D3 low-calcemic analog MC903, which is known to induce TSLP
production and atopic dermatitis, still developed epidermal hyperplasia and dermal cell
infiltrate including increased numbers of eosinophils, mast cells, and dermal dendritic
cells (Li, Hener et al. 2006).

Thus, treatment with MC903 is able to induce TSLP

expression in the absence of adaptive immune cells, and mature B and T cells are also
not required for the induction of MC903-mediated inflammation in the ear (Li, Hener et
al. 2006). Given the ability of TSLP, in the context of either TNF-α or IL-1, to induce
mast cell cytokine production (Allakhverdi, Smith et al. 2007) it is possible that mast cells
play a dynamic role in either initiating or perpetuating the inflammation caused by TSLP
overexpression. However, studies utilizing intradermal injection of recombinant TSLP
into RAG-/-, athymic nude mice, mast cell deficient mice (KitW-sh), and eosinophil deficient
mice (ΔdblGATA), highlighted the importance of T cells and eosinophils in the
development of TSLP-mediated skin inflammation while suggesting that mast cells
played a non crucial role (Jessup, Brewer et al. 2008).

It is clear that more work is

required to determine whether innate cells play a role in either the initiation or the
maintenance of TSLP-mediated inflammation in the skin, and whether these roles are
conserved in other tissue sites of TSLP-mediated inflammation such as the lung.
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While reports of TSLP-induced TH2 cytokine-mediated diseases have been largely
restricted to the skin and the lung, there are new reports emerging that TSLP may play a
role in the pathogenesis of other allergic diseases. Increased TSLP expression has
been reported in the nasal epithelium in a mouse model of allergic rhinitis and
neutralization of TSLP using a monoclonal anti-TSLP antibody inhibited the development
of disease (Miyata, Hatsushika et al. 2008). Also, increased TSLP expression has been
documented in the synovial fluid of arthritic joints of human patients with rheumatoid
arthritis (Koyama, Ozawa et al. 2007).

TSLP in the intestine
Although TSLP expression in the skin and the lung has been linked to pathologic TH2
cytokine-mediated responses, TSLP expression in the intestine appears to play an
important role in protective host immunity. Recent work has highlighted the importance
of IECs in influencing immune cell homeostasis and immunity to helminth parasites
(Rimoldi, Chieppa et al. 2005; Nenci, Becker et al. 2007; Zaph, Troy et al. 2007). IECspecific deletion of IKKβ resulted in susceptibility to the intestinal dwelling nematode
Trichuris and was correlated to decreased expression of TSLP (Zaph, Troy et al. 2007).
Despite being on a genetically resistant background, TSLPR-/- mice challenged with
Trichuris failed to clear worms at day 21 post-infection and produced the non-protective
TH1 cytokine IFN-γ (Zaph, Troy et al. 2007). The strong induction of TSLP mRNA upon
infection (Humphreys, Xu et al. 2008), and its requirement for efficient early worm
clearance (Zaph, Troy et al. 2007), indicate that TSLP is a critical component of
protective TH2 cytokine-mediated immune responses in the intestine.
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Despite these advances in the understanding of the potential role of TSLP-TSLPR
interactions in the intestine, many basic questions remain undefined and will form the
focus of this thesis research. Chapter 2 will be dedicated to defining and characterizing
the cellular sources and targets of TSLP in the GALT and large intestine under naïve,
homeostatic conditions.

Chapter 3 will explore the requirement for TSLP in the

generation of a host-protective TH2 cytokine-mediated immune response to the intestinal
helminth pathogen Trichuris muris. Finally, Chapter 4 will investigate the potential of
TSLP to regulate proinflammatory cytokine production in the intestine.
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Figure 3 TSLP promotes TH2 cytokine responses

Figure 3 TSLP promotes TH2 cytokine responses. Epithelial cell-derived TSLP (1)
can act to promote TH2 cytokine responses through interactions with DCs (2),
naïve CD4+ T cells (3), and granulocyte populations (4).
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Model Systems
Trichuris muris
Life cycle and transmission
Trichuris muris is a gastrointestinal nematode pathogen of mice that is commonly utilized
to model the human whipworm pathogen, Trichuris trichiura (Cliffe and Grencis 2004).
T. muris transmission occurs through the ingestion of infective eggs present in fecal
contamination. It is thought that the embryonated eggs hatch in the cecum (Panesar
and Croll 1980), and L1 larvae can be detected within the cecum within hours of
infection (Wakelin 1967). Larvae enter into the mucosal tissue of the large intestine
living within the epithelial cell layer, never penetrating through the basement membrane
into the lamina propria (Lee and Wright 1978; Tilney, Connelly et al. 2005). Larvae
undergo a series of four molts, reaching sexual maturity and adulthood after the fourth
molt occurring on day thirty-two (Cliffe and Grencis 2004). The anterior end of the worm
remains embedded within the epithelial cell layer; scanning and transmission electron
micrograph studies have revealed that the worm creates syncitial tunnels within
intestinal epithelial cells (Lee and Wright 1978). Though the anterior head of the worm
remains burrowed within the epithelial cell layer of the large intestine throughout the life
cycle, the body of the worm extends freely into the lumen of the intestine and in
adulthood can be visualized by the naked human eye. The extension of the body of the
worm outside of the epithelial cell layer permits copulation (Panesar and Croll 1980).
The life cycle is completed when following mating the female worm releases eggs into
the intestine, which are then shed within the feces of the host.

The eggs must then

embryonate over a period of several months to become infective (Cliffe and Grencis
2004) (Figure 4A).
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Public health impact
An estimated two billion individuals worldwide are infected with soil-transmitted
helminths (Colley, LoVerde et al. 2001; WHO 2009). Recent studies have estimated the
global prevalence of Trichuris trichiura at 604 million with an additional 3.2 billion
individuals at risk of infection (de Silva, Brooker et al. 2003; Bethony, Brooker et al.
2006). Children remain especially susceptible to infection and other risk factors include
living within a tropical climate, and poor sanitation (Hotez, Molyneux et al. 2007).
Currently, developing regions of Asia, Africa and Latin America have the highest rates of
Trichuris trichiura infection, with the highest incident rates being focused in areas of rural
poverty (Hotez, Brindley et al. 2008)

While trichuriasis itself is rarely fatal, clinical manifestations of the disease range from
impaired nutritional status, growth retardation, and lower educational achievement
(Callender, Grantham-McGregor et al. 1992; Nokes, Grantham-McGregor et al. 1992;
Nokes and Bundy 1994) to the more severe protein-losing enteropathy, chronic
dysentery, anemia, and rectal prolapse (Symons 1969; Bundy and Cooper 1989;
Grencis and Cooper 1996; Albonico, Crompton et al. 1999).

Additionally, 1.6 - 6.4

million disability-adjusted life years (DALY) are attributed to trichuriasis (Hotez, Fenwick
et al. 2009) indicating a substantial disease burden. Treatment with the anti-helminth
drugs albendazole or mebendazole is effective to induce the expulsion of the infective
worms (Hotez, Brindley et al. 2008), however the procurement and distribution of these
drugs remains an issue in the global fight to eradicate trichuriasis (Hotez, Fenwick et al.
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2009). The World Health Organization (WHO) estimates that less than half of the drugs
needed to treat trichuriasis globally are currently available (WHO 2008).

Trichuris muris as a model of protective TH2 cytokine-dependent immune responses
Investigation into Trichuris muris infection began as early as 1940 (Shikhobalova 1940)
but it was not until the 1960s that the importance of the immune response to infection
was appreciated (Campbell 1963; Wakelin 1967). Studies comparing Trichuris muris
infection across multiple mouse strains also revealed a host genetic component to
resistance, as worm expulsion varies between strains, with some strains demonstrating
resistance to infection and others failing to expel the worms and remaining chronically
infected for the lifetime of the host (Wakelin 1975). Although variation exists between
strains, the peak of the effector immune response in genetically-resistant mice is at day
21, and mice expel their worms between days 18-24 with complete clearance by day 32
post-infection.

CD4+ T cells are required for immunity to Trichuris muris. Adoptive transfer studies
demonstrated that transfer of CD4+ T cells into severe combined immunodeficient mice
(SCID) was sufficient to mediate resistance to infection (Else and Grencis 1996).
Antibody-mediated depletion studies have demonstrated that immunity to infection can
occur in the absence of CD8+ T cells (Koyama, Tamauchi et al. 1995). B cells also do
not appear to be required for host resistance in an intact animal. Trichuris-infected SCID
mice lacking all B and T lymphocytes were able to clear infection with the transfer of
CD4+ T cells alone (Else and Grencis 1996).

Additionally, µMT mice, which are

deficient in B cells, displayed intact TH2 cytokine-mediated host-protective immunity
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(Perrigoue, Saenz et al. 2009). Thus while CD8+ T cells and B cells may contribute to
resistance within an intact animal, worm expulsion and immunity can occur in their
absence.

Subsequent studies analyzing the role of CD4+ T cells in infection have revealed that
immunity to Trichuris muris is critically dependent on the generation of CD4+ TH2 cells
(reviewed in (Abbas, Murphy et al. 1996; O'Garra 1998; Murphy and Reiner 2002)) and
the production of IL-4, IL-9, and IL-13 (Else, Entwistle et al. 1993; Else, Finkelman et al.
1994; Koyama, Tamauchi et al. 1995; Else and Grencis 1996) (Figure 4B). TH2 cytokine
production in the intestine is associated with a number of physiologic changes that
correlate with worm expulsion, including mastocytosis, eosinophilia, smooth muscle
contraction and changes in epithelial cell turnover, all of which have been implicated in
expulsion of multiple helminth parasites (reviewed in (Finkelman, Shea-Donohue et al.
1997; Grencis 1997; Anthony, Rutitzky et al. 2007).

However, mastocytosis and

eosinophilia are not required for immunity to Trichuris muris infection, as either genetic
or antibody-mediated depletion of these cell subsets failed to alter worm expulsion (Betts
and Else 1999; Koyama and Ito 2000). Instead, parasite expulsion is correlated to TH2
cytokine-induced goblet cell hyperplasia and the production of goblet cell-specific factors
such as RELMβ and Gob5 (Zhou, Dong et al. 2001; Artis, Wang et al. 2004; Zaph, Troy
et al. 2007), smooth muscle hypercontractility (Khan, Richard et al. 2003), and increased
epithelial cell turnover (Cliffe, Humphreys et al. 2005).

In contrast to TH2 cytokine-dependent resistance, susceptibility to infection is
characterized by the development of CD4+ TH1 cells (reviewed in (Abbas, Murphy et al.
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1996; O'Garra 1998; Murphy and Reiner 2002) and is critically associated with the
production of IL-12 and IFN-γ (Else, Hultner et al. 1992; Else, Entwistle et al. 1993; Else,
Finkelman et al. 1994) (Figure 4B). In fact, in vivo antibody-mediated depletion of IFN-γ
in susceptible strains of mice is sufficient to induce resistance and worm expulsion (Else,
Finkelman et al. 1994). Conversely, administration of recombinant IL-12 to genetically
resistant strains of mice results in susceptibility and chronic infection (Bancroft, Else et
al. 1997).

34

Figure 4 Trichuris muris life cycle and immune response

Figure 4 Life cycle and immune regulation of Trichuris muris infection. (A) Eggs
are ingested orally and hatch in the cecum (1). Larval parasites then invade IECs
that line the crypts of the cecum and proximal colon (2), where they undergo four
molts to become sexually mature adults and release eggs into the environment (3,
4). (B) Different Trichuris-specific immune responses determine resistance and
susceptibility to infection in inbred mice. TH1 associated cytokines (IL-12, IFN-γ)
promote chronic infection in AKR mice, while TH2 associated cytokines (IL-2, IL-9,
IL-13) promote larval expulsion and immunity in resistant strains such as C57/BL6,
and Balb/c.

35

Dextran Sulfate Sodium (DSS) colitis: a murine model of inflammatory bowel
disease (IBD)
IBD: Disease and public health impact
IBD in humans comprises multiple pathologies and disorders, the two main forms being
Crohn’s disease and ulcerative colitis (Cho 2008). Both diseases present with systemic
symptoms such as weight loss, fever, and fatigue as well as gastrointestinal symptoms
ranging from abdominal pain and diarrhea to rectal bleeding (Strober, Fuss et al. 2007).
Clinical onset generally occurs between age 20-30 and both diseases are characterized
by their chronic and relapsing nature (Cobrin and Abreu 2005; Xavier and Podolsky
2007).

Disease incidence is generally low in developing nations, with substantially

higher disease rates in first world countries (Gismera and Aladren 2008). It is estimated
that between 7,000 - 46,000 cases of ulcerative colitis and 10,000 - 47,000 cases of
Crohn’s diseases are newly diagnosed each year in North America alone (Loftus 2004).
The increasing disease rates in developed nations indicate a role for environmental
factors in driving IBD (Xavier and Podolsky 2007; Gismera and Aladren 2008).
Genome-wide screens have also identified a genetic component to IBD susceptibility
with multiple IBD-susceptibility loci being identified.

These loci include immune

response genes, with mutations in the genes encoding the bacterial sensing protein
NOD2 and the IL-23 receptor complex being inked to increased incidence of Crohn’s
disease (Xavier and Podolsky 2007).

While Crohn’s disease and ulcerative colitis present with similar symptoms, they are
separate diseases. Crohn’s disease may target any section of the gastrointestinal tract
and is characterized histopathogically by transmural inflammation, macrophage
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aggregation, and the presence of non-caseating granulomas (Xavier and Podolsky
2007). In contrast, ulcerative colitis is restricted to the large intestine and results in
extensive superficial ulceration with depletion of goblet cell-derived mucin, neutrophilia in
the lamina propria, and micro-abscesses in the crypt (Xavier and Podolsky 2007).
Immunologically, the pathology associated with Crohn’s disease is characterized by
increased production of IL-12, IL-23, IFN-γ, and IL-17, while ulcerative colitis is
associated with excess IL-13 production (Strober, Fuss et al. 2007).

Although the exact etiology of IBD remains poorly defined, there is strong evidence to
suggest that inappropriate immune responses to innocuous commensal bacteria help to
drive disease (Strober, Fuss et al. 2007; Xavier and Podolsky 2007; Cho 2008; Round
and Mazmanian 2009). Increased barrier permeability is associated with disease, and
subsets of patients respond to antibiotic therapy (Xavier and Podolsky 2007).
Additionally, multiple murine models of IBD are ameliorated if animals are either raised
in germ-free conditions or treated with antibiotics (Round and Mazmanian 2009).
Further, while it is difficult to determine cause versus effect, patients with IBD have
altered commensal flora compared to healthy control subjects (Frank, St Amand et al.
2007).

DSS colitis: A chemical-induced experimental colitis model
Dextran sulfate sodium (DSS) is a 30 - 50 kDa polyanionic derivative of dextran that
when administered orally at concentrations between 3 – 10% in the drinking water
induces colitis in mice (Okayasu, Hatakeyama et al. 1990).

DSS is thought to be toxic

to IECs (Kitajima, Takuma et al. 1999), and induces IEC damage and increased barrier
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permeability (Kitajima, Takuma et al. 1999).

DSS-colitis presents with weight loss,

alterations in fecal consistency, rectal bleeding, and increases in mouse morbidity
(Okayasu, Hatakeyama et al. 1990). Histopathologically, DSS colitis is characterized by
colonic shortening, immune cell recruitment, neutrophilic infiltration, loss of crypt
architecture, goblet cell hypoplasia, and the formation of focal ulcerations (Okayasu,
Hatakeyama et al. 1990; Melgar, Karlsson et al. 2005).

Lymphocytes do not appear to be required for the onset of colitis, as DSS-treated SCID
mice still develop disease (Dieleman, Ridwan et al. 1994). However, lymphocytes are
recruited to the site of inflammation and produce cytokines that contribute to the
maintenance and severity of disease.

For example, RAG-1 deficient mice exhibited

reduced disease symptoms and severity compared to WT mice following treatment with
1.5% DSS (Kim, Seo et al. 2006).

Acute colitis is characterized by CD4+ T cell

production of IFN-γ; however, if the colitis is allowed to progress and become chronic
both TH1 and TH2 CD4+ T cells are present (Dieleman, Palmen et al. 1998).

The

proinflammatory cytokines TNF-α, IL-6, and IFN-γ are though to contribute to tissue
damage (Strober, Fuss et al. 2002). However, more recent work has also indicated an
important role for IL-23 and IL-17 (Ogawa, Andoh et al. 2004).

Conclusion
Together Trichuris muris infection and DSS-induced colitis provide relevant model
systems in which the importance of TSLP-TSLPR interactions in the intestine can be
assessed in vivo. Chapter 3 of this thesis will employ the Trichuris muris infection model
to explore the requirement for TSLP-TSLPR interactions in the generation of a host-
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protective TH2 cytokine response in the intestine. The DSS colitis model will be used in
Chapter 4 to examine the ability of TSLP to influence intestinal proinflammatory cytokine
production and inflammation.
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CHAPTER 2: Characterization of TSLP-TSLPR expression in the
gastrointestinal lymphoid tissues (GALT)

Abstract
While TSLP-TSLPR interactions have been shown to influence intestinal immune
homeostasis, to date the cellular sources and targets of TSLP in the GALT and the large
intestine have not been comprehensively analyzed. We found that under resting steady
state conditions, IECs from WT naïve mice constitutively express TSLP at both the
mRNA and protein level in the cecum and large intestine.

Analysis of surface co-

expression of TSLP-α chain and CD127, which form the functional TSLPR complex,
found TSLPR complex to be expressed on splenic and GALT CD11c+ DCs, irrespective
of DC subset or activation status. In vitro studies utilizing BMDCs found the TSLPR-α
chain to be dynamically upregulated by externally-derived factors and a variety of hostderived cytokines. Additionally, TSLPR complex expression was exhibited by mast cells
and basophils in the spleen and by CD3+ CD4+ T cells in the spleen and GALT.
Functionality of receptor expression was assessed by direct ex vivo stimulation of
splenoctye or MLN cultures with rTSLP. We found that both splenic and MLN CD11c+
DCs and CD4+ T cells responded to TSLP and upregulated phopho-STAT5. Collectively
these results identify potential cellular targets of TSLP-TSLPR interactions in the
intestine and highlight the ability of TSLP to influence components of both the innate and
adaptive immune system.

40

Introduction
TSLP was originally isolated and identified as a product of the thymic stromal cell clone
Z210R.1, which induced the proliferation of the nonadherent B lymphoid cell line NAG8/7
(Friend, Hosier et al. 1994). Subsequent work utilizing cDNA libraries from different cells,
cell lines, or purified primary cells demonstrated TSLP to be most highly expressed in
the skin and lung (Soumelis, Reche et al. 2002). Although TSLP mRNA expression was
noted in the small intestine during initial characterization studies (Sims, Williams et al.
2000), Rimoldi et al. were the first to demonstrate expression of TSLP protein in the
large intestine.

Their work identified a role TSLP in the maintenance of intestinal

immune homeostasis through the preferential promotion of TH2 cell differentiation
(Rimoldi, Chieppa et al. 2005). However, the expression pattern of TSLP throughout the
different microenvironments of the intestinal tract remains poorly defined.

While both chains of the heterodimeric TSLPR have been previously defined (Park,
Martin et al. 2000), detection of cells expressing the unique TSLPR-α chain has been
limited by lack of a reliable monoclonal antibody (mAb) to detect cellular expression by
flow cytometry. Initial experiments utilizing binding studies identified macrophages and
monocytes as having high binding affinities (Park, Martin et al. 2000). These results
were confirmed and expanded to include CD11c+ DC as having high levels of expression
of TSLPR, using TSLPR mRNA levels as a surrogate for surface expression (Reche,
Soumelis et al. 2001). Expression of TSLPR on DCs was shown to be functional as
TSLP potently activates human monocyte-derived DCs, upregulating surface expression
of co-stimulatory molecules such as CD80 and CD86 and inducing the production of the
chemokines CCL17 and CCL22 (Reche, Soumelis et al. 2001; Soumelis, Reche et al.
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2002). Functional readouts such as activation of cytokine production have also identified
mast cell and CD4+ T cell expression of TSLPR (Allakhverdi, Comeau et al. 2007; Omori
and Ziegler 2007; Rochman, Watanabe et al. 2007).

Despite these advances in

identifying possible cellular targets of TSLP, the majority of these studies were
conducted in vitro on cultured cells. For example, although purified naïve CD4+ T cells
maintained in short term culture have been shown to be responsive to TSLP (Omori and
Ziegler 2007), the expression of TSLPR on CD4+ T cells taken directly ex vivo has not
been assessed. Thus, the cellular targets of TSLP in vivo remain largely unknown;
further it is not clear whether the cellular expression pattern of the TSLPR complex is
altered or influenced by tissue specific environments. In this chapter, we characterize
for the first time the expression of both TSLP and the TSLPR complex within the GALT
and large intestine. We demonstrate constitutive production of TSLP mRNA and protein
in large intestine IECs. Further, our findings identify TSLPR complex expression on
DCs, mast cells, basophils, and CD4+ T cells isolated from naïve WT mice.
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Materials and Methods
Animals
Wild type C57BL/6 mice were obtained from Jackson Laboratories (Bar Harbor, ME).
TSLPR+/+ and TSLPR-/- mice were obtained from Dr. James Ihle at St. Jude’s Children’s
Hospital, Nashville TN.

Mice were bred and maintained in a specific-pathogen free

environment at the University of Pennsylvania. Animal protocols were approved by the
University of Pennsylvania Institutional Animal Care and Use Committee (IACUC) and all
experiments were carried out following the guidelines of the University of Pennsylvania
IACUC.

Parasites and antigens
Trichuris muris was maintained in genetically susceptible animals (Wakelin 1967;
Wakelin 1969); isolation of Trichuris excretory-secretory (ES) antigen (Ag) and eggs was
carried out as previously described (Artis, Villarino et al. 2004).

Isolation and preparation of cells
At necropsy, spleen, MLN, cecal patch, peyer’s patch, were harvested and single-cell
suspensions were prepared in complete T cell medium (CTCM) (DMEM supplemented
with 10% heat-inactivated FBS, 2mM glutamine, 100 U/ml penicillin, 100 µg/ml
streptomycin, 25mM HEPES, and 5 x 10-5 M 2-ME).

If dendritic cells were to be

examined, tissues were first minced and incubated in 5 mls of digestive enzyme solution
(0.5 mg/ml collagenase and 0.05% DNAse in CTCM) for 25 minutes at 37 °C while
shaking prior to the creation of single-cell suspensions.

43

Isolation of intraepithelial and lamina propria lymphocytes
At necropsy, small intestine and large intestine were removed and put into separate
Petri-dishes with pre-warmed CTCM. Cecal patch and Peyer’s patches were removed
and placed in 2 mls CTCM on ice. Intestines were cut longitudinally and feces were
removed by shaking in a large Petri dish of PBS. Intestines were further cleaned and
mucus removed by shaking in a clean Petri dish until PBS remained clear. Intestines
were then cut into small sections and placed in 20 mls prewarmed epithelial strip buffer
(1mM EDTA, 1 mM DTT, 5% fetal bovine serum, 100 U/ml penicillin, 100 µg/ml
streptomycin) and incubated for 20 minutes at 37 °C while shaking. Tissue was allowed
to settle and supernatant was filtered through a cell strainer for isolation of intraepithelial
lymphocytes (IELs). Purification of IELs was conducted though utilization of a Percoll
gradient. Briefly, cells were resuspended in 5 mls of 40% Percoll, underlayed with 70%
Percoll, and the spun for 20 minutes at 600 g with the brake removed. Cells were then
pipetted from the interface and washed twice with CTCM, before resuspending in final
volume. For isolation of lamina propria lymphocytes (LPLs), intestines were washed
with serum-free media 3 times, and then minced using a razor blade in a small Petri
dish. Intestines were then resuspended in 15 mls of digestive enzyme solution (0.5
mg/ml collagenase and 0.05% DNAse in CTCM) and incubated for 30 minutes 37 °C
while shaking.

The entire contents of each tube were then filtered through a cell

strainer, and intestines were mashed in the cell strainer using the back end of a 3 ml
syringe. The strainers were then washed with 15 mls CTCM. Cells were then pelleted
and washed with CTCM before the Percoll purification was preformed as described
above.
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Flow cytometry and intracellular cytokine staining
For ex vivo surface staining, cells were washed in PBS and stained with the fixable aqua
blue viability dye (Invitrogen) to assess viability. Cells were then washed and stained
with fluorochrome-conjugated antibodies against CD3, CD19, CD4, CD8α, CD11c,
CD11b, CD103, Gr-1, FcεRI, ckit, CD49b (DX5), CD127, and TSLPR.

Cells were

analyzed by flow cytometry on a FACS Canto II using CellQuest Pro software (BD
Pharmingen); further analysis was then carried out using FlowJo software (Treestar,
Inc.).

For phospho-STAT5 staining, cells were rested overnight in 2% fetal bovine

CTCM at 37 °C. Cells were then stimulated with rTSLP (final concentration 100 ng/ml)
for various amounts of time at 37 °C. Cells were fixed for 10 minutes at 37 °C by adding
in 16% PFA for a final concentration of 2%. Cells were then washed with PBS and
permeabilized for 30 minutes on ice with the addition of 1 ml of 90% ice-cold methanol.
Following permeabilization, cells were washed twice with FACs buffer and stained for 1
hour at room temperature with fluorochrome-conjugated antibodies against CD4, CD11c,
and Phospho-STAT5 (BD Pharmingen). Cells were then analyzed by flow cytometry as
described above.

Bone marrow-derived dendritic cells
Bone marrow derived-dendritic cells (BMDCs) were derived as follows. Bone marrow
from WT C57BL/6 mice was plated in 6 well cell culture plates in RPMI 1640
supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 5 x 10-5 M 2-ME, 10%
FBS, 2mM L-glutamine, and 20 ng/ml GM-CSF (Peprotech). Media was changed at
days 3, 6 and 8; cells were harvested at day 9. BMDCs were plated out at 4 x 106
cells/ml and mixed 1:1 with either media alone, LPS (final concentration 100 ng/ml), CpG
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(final concentration 10 µg/ml), Trichuris ES antigen, S. mansoni egg antigen, papain
(final concentration 50ng/ml), IL-4 (final concentration 40 ng/ml), IFN-γ (final
concentration 100 U/ml), IL-10 (final concentration 10 ng/ml), TGF-β (final concentration
1 ng/ml), IL-6 (final concentration 10 ng/ml), or rTSLP (final concentration 10 or 100
ng/ml from R & D), for 8 h.

RNA isolation and real-time PCR
RNA was isolated from intestinal tissues of mice using a Trizol extraction and from
BMDCs using RNEasy Spin Columns (Qiagen). Tissues were first disrupted in a tissue
homogenizer (TissueLyzer, Qiagen).

RNA was extracted from purified cells using

RNeasy spin columns (Qiagen). cDNA was synthesized from the isolated RNA using
Superscript Reverse Transcriptase (Invitrogen). Quantitative real-time PCR was carried
out on cDNA samples using commercial primer sets (Qiagen) and SYBR Green
chemistry. All reactions were run on an ABI 7500 Fast Real-Time PCR System (Applied
Biosystems). Samples are normalized to naïve controls unless otherwise stated.

Tissue staining
At necropsy, cecal and proximal large intestine sections were removed and snap-frozen
in OCT medium (Tissue Tek, Sakura Inc.). 5 µm sections were cut and stained for TSLP
using a biotinylated monoclonal anti-TSLP antibody (eBioscience, San Diego, CA).
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Results
Constitutive expression of TSLP in intestinal epithelial cells
The GI tract is composed of region-specific microenvironments defined by the presence
of distinct accessory cell and lymphocyte populations and varied populations of
commensal bacteria (Mowat 2003; Macdonald and Monteleone 2005; Artis 2008). The
large intestine differs from the small intestine in immuno-regulatory pressures as it
carries a higher level of commensal bacteria and is a common site for intestinal
inflammatory diseases like ulcerative colitis (Tlaskalova-Hogenova, Stepankova et al.
2004).

We sought to examine whether basal expression of TSLP differed in these

distinct microenvironments. There was low expression of TSLP in the small intestine of
naïve mice (Figure 5A).

TSLP mRNA expression was also detected throughout the

large intestine, with the highest expression levels in the proximal large intestine (Figure
5A). TSLP protein expression was examined by immunofluorescent (IF) staining of
cryosections of cecum and large intestine.

In the cecum, TSLP was found

predominately in mature enterocytes located at the crypt table whereas in the proximal
large intestine, TSLP was expressed throughout the length of the crypt (Figure 5B). The
variable expression of TSLP throughout the length of GI tract suggests differential
regulation depending on microenvironment. Although the mechanisms regulating TSLP
expression remain undefined, our results demonstrate constitutive IEC TSLP production
in the large intestine.
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Figure 5 TSLP is constitutively expressed in intestinal epithelial cells

Figure 5. TSLP is basally expressed in the large intestine. (A) RNA was isolated
from sections of the intestine and expression of TSLP was analyzed by RT-PCR.
Values represent % of actin expression in each sample. DSI, distal small intestine,
Ce, cecum, prox, proximal, dis, distal. Error bars indicate s.e.m. (B) IF staining of
TSLP (red) in intestinal cryosections, co-stained with DAPI (blue). Bar, 50 µm.
Data represents two individual experiments with 2-3 mice per group.
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TSLPR and IL-7Rα (CD127) are co-expressed on CD11c+ DCs
While both human and murine CD11c+ DCs have been shown to be responsive to TSLP
in vitro (Soumelis, Reche et al. 2002; Rimoldi, Chieppa et al. 2005; Zaph, Troy et al.
2007), expression of TSLPR-α chain and CD127 on DCs directly ex vivo has not been
extensively characterized.

Further, it is not known if signals present in the tissue

microenvironment can influence expression of either chain of the TSLPR complex. In
order to fully characterize DC expression of TSLPR and CD127 within the GALT, cells
were isolated from the spleen, mesenteric lymph node (MLN), cecal patch (CP), and the
lamina propria of the large intestine (large intestine lamina propria lymphocytes LI LPLs)
of naïve, WT C57/BL6 mice, stained directly ex vivo and examined by flow cytometry;
DCs were gated as CD3-CD19- CD11c+. The specificity of the APC-labeled anti-TSLP
mAb was assessed and no cross reactivity was observed in splenic DCs isolated from
TSLPR-/- mice (Figure 6A). We found that TSLPR expression was detected on DCs
isolated from the spleen and each compartment of the GALT examined, (Figure 6B
upper panel). DCs isolated from the large intestine lamina propria (LI LPL) had the
lowest expression levels of TSLPR. As high affinity ligand binding and signaling of TSLP
requires pairing of the TSLPR-α chain with CD127, DC co-expression of CD127 was
examined. CD11c+ TSLPR+ DCs co-expressed CD127 in each tissue examined (Figure
6B lower panel), indicating heterodimeric TSLPR expression. Intestinal DCs can be
further separated into subsets based on expression of CD8α, CD11b, and CD103 with
specific functions being ascribed to each phenotype (Kelsall 2008). Analysis of TSLPR
complex expression in CD8α+ CD11b-, CD8α- CD11b+, CD8α- CD11b-, and CD103+ DCs
did not reveal substantial differences in between subsets in any of the GALT tissues
analyzed (data not shown).

Additionally, TSLPR expression does not appear to be
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linked to the activation state of DCs, as high expression of MHC class II did not correlate
to increased expression of TSLPR in GALT DCs (data not shown). Taken together,
these data suggest that DCs from peripheral sites such as the spleen and from the
GALT tissue express the functional heterodimeric TSLPR irrespective of activation
status as measured by MHC class II expression levels.

While the dynamic expression of TSLP from EC cells is known to be regulated by a
number of external and host-derived factors (Summarized in Figure 1 and Table 1)
(Saenz, Taylor et al. 2008), the regulation of DC TSLPR expression remains largely
undefined. In order to elucidate factors that could impact DC TSLPR expression, we
utilized bone marrow-derived dendritic cells (BMDCs) as in vitro model system. BMDCs
were generated and found to express the TSLPR-α chain under resting conditions
(Figure 6C). First we assessed whether stimulation with externally derived products
such as TLR ligands, secreted helminth products, or allergens influenced TSLPR
expression. Stimulation with the TLR agonists LPS and CpG resulted in little to no
increase in TSLPR expression above steady state levels (Figure 6C). However,
exposure of BDMCs to helminth-derived products such as Trichuris ES antigen or
Schistosoma mansoni egg antigen (SEA) resulted in a small but consistent elevation of
TSLPR expression (Figure 6C). These finding are consistent with increased levels of
TSLPR mRNA found in whole intestinal tissue samples following Trichuris infection
(Humphreys, Xu et al. 2008) or in lung tissue after exposure to Schistosoma mansoni
eggs (Ramalingam, Pesce et al. 2009). Treatment with the cysteine protease allergen
papain resulted in strong upregulation of TSLPR (Figure 6C). Next we tested whether
cytokine signaling on the BMDCs could regulate TSLPR expression. While stimulation
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with IL-4, TGF-β, and IL-6 resulted in moderate upregulation of TSLPR (Figure 6D),
treatment with IFN-γ and IL-10 resulted in strong upregulation of TSLPR in BMDCs
(Figure 6D). BMDCs were also treated with the TH2-associated cytokine IL-25 which
failed to increase TSLPR expression (data not shown). Stimulation with rTSLP resulted
in a down-regulation of surface TSLPR expression (Figure 6E). Further studies need to
be done to determine if this decrease is representative of receptor endocytosis. BMDC
expression of CD127 was also examined following stimulation and failed to show
dynamic regulation in surface expression (data not shown). As BMDC expression of
CD127 is lower than on CD11c+ DCs isolated directly ex vivo, these results were also
confirmed using RTPCR, which showed no significant changes in CD127 mRNA levels
following stimulation (data not shown).

Additionally, in order to investigate the relationship between DC activation and TSLPR
expression, surface expression of the co-stimulatory molecule CD86 was examined. As
expected, stimulation of BMDCs with LPS and IFN-γ strongly increased CD86
expression (Figure 6C,D lower panel). However, the increase in activation status (as
measured by the upregulation of co-stimulatory molecules) did not directly correlate to
increased TSLPR expression, as strong upregulation of TSLPR was seen following IFNγ but not LPS stimulation (Figure 6C,D). Further supporting this, TSLPR expression was
increased in response to IL-10 and TGF-β (Figure 6C, D), two cytokines that do not
activate BMDCs. These results indicate that TSLPR expression is not directly linked to
the activation status of the DC.
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Figure 6 GALT DCs co-express TSLPR-α chain and CD127
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Figure 6 GALT DCs co-express TSLPR-α chain and CD127
Figure 6 CD11c+ DCs from the GALT co-express TSLPR and CD127. (A) Splenic
CD11c+ DCs from WT and TSLPR-/- mice expression of TSLPR assayed by flow
cytometry. (B) Expression of TSLPR complex on DCs isolated from the spleen,
mesenteric lymph node (MLN), cecal patch (CP), large intestine lamina propria (LI
LP). Top panel, TSLPR expression, plots are gated on viable CD3- CD19- CD11c+
cells. Numbers are frequencies of TSLPR+ cells. Bottom panel, CD127 coexpression, plots are gated on CD3- CD19- CD11c+ TSLPR+ cells. WT, black line,
unstained controlled, solid gray histogram. (C-E) BMDC expression of TSLPR
following 8 hr stimulation. Top panel TSLPR expression, plots are gated on
CD11c+ cells. FMO control, solid gray histogram, media alone, black line,
stimulation, dashed gray line. Numbers equal mean fluorescent intensity. Bottom
panel CD86 expression, media, black line, stimulation, gray dashed line. (C)
Externally-derived stimuli. (D) Host-derived stimuli. (E) rTSLP. Data represents
three individual experiments with 3-4 mice per group (A, B) or two independent
experiments with conditions run in duplicate (D-E).
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TSLPR complex expression on macrophages and granulocytes
Although the majority of studies to date have focused on the ability of TSLP to influence
DC cell function, recent reports have highlighted that TSLP may also act upon other
innate cell populations such as mast cells (Allakhverdi, Comeau et al. 2007). However,
whether other cells of the innate immune system express the TSLPR complex remains
unknown. To investigate this, TSLPR and CD127 surface expression was analyzed on
macrophages (SSCAhi, F4/80+), neutrophils (Gr1+), eosinophils (SiglecF+), basophils
(CD3- CD19- FcεR1+ CD49b+), and mast cells (CD3- CD19- FcεR1+ ckit+). Cells were
isolated from the blood, spleen, MLN, CP, and LI LP, and examined directly ex vivo for
TSLPR complex surface expression.

Surface expression did not appear to vary

between tissue types examined regardless of cell population (data not shown) however,
due to the rarity of certain cell subsets in GALT tissues under steady state conditions;
the most robust data was generated from the spleen (Figure 7). While macrophages,
neutrophils, and eosinophils expressed low levels of TSLPR, they failed to co-express
CD127 (Figure 7A), indicating these cells are not responsive to TSLP in the steady state.
Consistent with previous reports of mast cell sensitivity to TSLP (Allakhverdi, Comeau et
al. 2007; Allakhverdi, Smith et al. 2007), mast cells exhibited co-expression of TSLPR
and CD127 (Figure 7B). While basophils have been recently identified as a cellular
source of TSLP (Sokol, Barton et al. 2008), they have not previously been reported to be
sensitive to TSLP stimulation. However, examination of both splenic (Figure 7B) and
circulating basophils in the blood (data not shown) revealed co expression of TSLPR
and CD127. In order to determine if TSLP could impact the homeostasis of either mast
cell or basophil populations, rTSLP was administered i.p. for four consecutive days.
Administration of rTSLP did not influence mast cell populations but resulted in a
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selective increase in basophils (Figure 7C) (Perrigoue, Saenz et al. 2009). At present it
remains undetermined if TSLP is inducing either increased basophil production/release
from the bone marrow or if TSLP is acting to increase basophil survival in the periphery.
Taken together, these findings suggest that TSLP has the ability to influence innate
immunity by impacting mast cells and basophils.
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Figure 7 TSLPR complex expression on macrophage and granulocyte cell
populations

Figure 7 TSLPR complex expression on macrophage and granulocyte cell
populations. (A) Splenic macrophage, neutrophil, and eosinophil expression of
TSLPR (top panel) and CD127 (bottom panel). WT, black histogram, FMO, gray
histogram, numbers indicate mean fluorescent intensity. (B) Splenic mast cell and
basophil expression of TSLPR (top panel) and CD127 (bottom panel). WT, black
histogram, FMO, gray histogram, numbers indicate mean fluorescent intensity (C)
Administration of rTSLP results in an increased frequency of basophils in the
blood. Flow cytometry of basophil frequencies in blood of mice treated daily for 4
d with rTSLP. Top panel, expression of IL-4-eGFP by non-B, non-T cells from the
peripheral blood. Bottom panel basophil frequencies in IL-4-eGFP+, non-B, non-T
cell populations. Numbers adjacent to outlined areas indicate percent among total
cells of gated population. Data represents three independent experiments with 2-4
mice per group.
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CD3+ CD4+ T cells co-express TSLPR and CD127
While TSLP maintains the ability to modulate CD4+ T cell function by influencing DCderived signals (Ziegler and Liu 2006; Liu 2007; Liu, Soumelis et al. 2007), TSLP can
also directly impact CD4+ T cell function (Omori and Ziegler 2007; Rochman, Watanabe
et al. 2007; He, Oyoshi et al. 2008; Lu, Wang et al. 2009). However, the majority of
these studies have been conducted in vitro, and it remains unclear whether CD4+ T cells
express the TSLPR complex in vivo under steady state conditions. Also, it is unknown
whether different tissue microenvironments can impact CD4+ T cell TSLPR expression.
To investigate this, lymphocytes were isolated from the spleen, MLN, CP, and LI LP and
examined for TSLPR and CD127 surface co-expression by flow cytometry. Viable, CD3+
CD4+ T cells isolated from the spleen, MLN, and CP showed low but detectable levels of
TSLPR expression (Figure 8).

CD4+ T cell expression of TSLPR in the LI LP was

extremely low, with only marginal staining detected above CD4+ T cells isolated from the
LP of TSLPR-/- mice (Figure 8). Similar to LI LP DCs, it is unknown whether this lack of
expression is a result of tissue specific regulation or receptor endocytosis upon ligand
binding. Co-expression of the second chain of the TSLPR complex, CD127, was also
examined on CD4+ TSLPR+ cells.

All CD4+ TSLPR+ T cells co-expressed CD127

irrespective of the tissue they were isolated from (Figure 8 bottom panel). As CD127
binds with the common γ chain (CD132) to form the functional IL-7 receptor, and IL-7 is a
critical survival signal for CD4+ T cells (Mazzucchelli and Durum 2007; Rochman,
Spolski et al. 2009), this result is largely expected.

However, detection of the

heterodimeric TSLPR complex on CD4+ T cells from WT naïve mice under steady state
conditions indicates that TSLP may be able to influence CD4+ T cell function without
other accessory signals or prior stimulation.
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Figure 8 TSLPR and CD127 co-expression on CD3+ CD4+ T cells

Figure 8 TSLPR and CD127 co-expression on CD3+ CD4+ T cells. Top panel,
TSLPR expression on CD4+ T cells isolated from the spleen, mesenteric lymph
node (MLN), cecal patch (CP), large intestine lamina propria (LI LP). Plots are
gated on viable CD3+ CD4+ cells. Numbers indicate frequencies of TSLPR+ cells.
Solid gray histogram TSLPR-/-, black line, WT. Bottom panel, CD127 coexpression, plots are gated on CD3+CD4+TSLPR+ cells. Solid gray histogram,
unstained controlled, WT, black line.
Data represent three independent
experiments with 3-4 mice per group.
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Recombinant TSLP induces phospho-STAT5 in CD11c+ and CD4+ T cells directly
ex vivo
Initial characterization of TSLP-TSLPR interactions found that binding of TSLP ligand to
the TSLPR complex results in activation of STAT-5a and STAT5b in the murine B
lymphoid cell line NAG8/7 and in human HepG2 cells transfected to express both chains
of the receptor (Isaksen, Baumann et al. 1999; Levin, Koelling et al. 1999). More recent
work has shown that following in vitro stimulation, both human and murine CD4+ T cells
respond to TSLP with increased levels of phospho-STAT5 being observed (Omori and
Ziegler 2007; Rochman, Watanabe et al. 2007). In order to investigate whether the coexpression of TSLPR and CD127 on both CD4+ T cells and DCs isolated from the GALT
resulted in the formation of a functional TSLPR complex, we sought to determine if these
cells could respond directly ex vivo to TSLP and phosphorylate STAT5.

To examine the functionality of DC TSLPR complex expression, spleens and MLNs were
harvested from WT C57/B6 mice and TSLPR-/- mice and whole unfractionated cell
cultures were rested overnight in low serum media prior to stimulation with rTSLP for 15
or 30 minutes.

Following stimulation, cells were immediately fixed and stained for

phospho-STAT5. Stimulation with GMCSF was utilized as a positive control for DC
phospho-STAT5 staining (Figure 9A, B bottom panel), as it is known to signal through
STAT5 (Martinez-Moczygemba and Huston 2003). As expected, stimulation with TSLP
did not result in any upregulation of phospho-STAT5 in splenic or MLN DCs isolated
from TSLPR-/- mice at any time point (Figure 9A, B top panel and data not shown).
However, TSLP stimulation did result in a small but consistent upregulation of phosphoSTAT5 in WT DCs in both tissues examined at 15 minutes post stimulation (Figure 9A, B
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middle panel). Further, the same level of phosphorylation persisted at 30 minutes in
both the spleen and MLN (data not shown), indicating sustained signaling. These results
indicate that TSLPR expression on both splenic and MLN DCs is functional and that
these DCs are capable of responding to TSLP without prior stimulation.

We next examined whether CD4+ T cells could respond to TSLP directly ex vivo without
any activation or additional stimuli. Cells were isolated and rested as previously stated
prior to TSLP stimulation. Consistent with the DC results (Figure 9A, B) addition of
rTSLP to spleen and MLN cell cultures from TSLPR-/- mice failed to result in the
upregulation of phospho-STAT5 at any time point (Figure 9C, D and data not shown).
CD4+ T cells from both the spleen and the MLN responded to rTSLP with between 1520% of CD4+ T cells staining positive for phospho-STAT5 (Figure 9C, D). This level of
phosphorylation was not sustained as a reduction in phospho-STAT5 cells was observed
at 30 minutes following stimulation (data not shown). However, CD4+ phospho-STAT5+
cells were detected at time points as late as ninety minutes post-stimulation in some
experiments, potentially indicating sustained signaling in some cells (data not shown).
Taken together, these data demonstrate that CD4+ T cells from naïve WT mice express
the functional TSLPR complex and can respond to TSLP without in vitro activation or
stimulation.
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Figure 9 rTSLP activates phospho-STAT5 in CD4+ T cells and CD11c+ DCs

Figure 9 rTSLP activates phospho-STAT5 in CD11c+ and CD4+ T cells isolated
from the GALT. Whole splenocyte or MLN cultures were rested overnight prior to
stimulation with rTSLP or GMCSF. Cells were fixed and intracellularly stained and
were analyzed by flow cytometry. (A) Whole splenocyte cultures, gated on
CD11c+ cells. (B) Whole MLN, gated on CD11c+ cells. (C) Whole splenocyte
cultures, gated on CD4+. (D) Whole MLN cultures, gated on CD4+. Numbers
represent frequency of phospho-STAT5+ cells. Data represent one experiment
with 3 mice per group.
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Discussion
Collectively, these results identify the cellular sources and targets of TSLP in the GALT
and large intestine. We show for the first time that TSLP is constitutively expressed
throughout the large intestine at both the mRNA and protein level under homeostatic
conditions. Immunofluorescent staining indicates IECs as the dominant source of TSLP.
Further, we demonstrate that DCs isolated from GALT tissues co-express both chains of
the TSLPR complex and can respond to rTSLP stimulation directly ex vivo. We confirm
mast cell expression of the TSLPR complex and identify receptor complex expression on
basophils. Additionally, administration of rTSLP selectively increases the frequency of
circulating basophils. Examination of CD4+ T cells from the GALT revealed TSLPR
complex expression and the ability to respond to TSLP and phosphorylate STAT5
without the presence of additional stimuli. These results indicate the complex nature of
TSLP-TSLPR interactions in GALT tissues, and indicate that TSLP may directly impact
both innate and adaptive immune cell populations under steady state conditions.

While the ability of TSLP to influence immune-mediated inflammation in the skin and the
lung has been well characterized (Liu, Soumelis et al. 2007), the functional biology of
TSLP in the intestine has only recently begun to be investigated. TSLP expression in
the small intestine was noted early (Sims, Williams et al. 2000), but it was not until the
work of Rescigno and colleagues that TSLP was appreciated to participate in intestinal
immune homeostasis (Rimoldi, Chieppa et al. 2005).

Human colonic epithelial cells

were demonstrated to produce bioactive TSLP that could influence DC function (Rimoldi,
Chieppa et al. 2005).

Our findings in the murine system also identify IECs as a

dominant source of TSLP in the intestine, but additionally highlight possible differences
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in expression between different intestinal microenvironments (Figure 5). As TSLP
expression can be induced through exposure to TLR ligands (Rimoldi, Chieppa et al.
2005; Allakhverdi, Comeau et al. 2007; Kato, Favoreto et al. 2007; Zeuthen, Fink et al.
2008) and commensal bacteria have been demonstrated to influence cytokine
production in the intestine (Ivanov, Frutos Rde et al. 2008; Zaph, Du et al. 2008), it is
possible that alterations in the abundance or composition of communal bacterial
populations in the distinct regions in the GI tract may influence TSLP mRNA expression
either directly or indirectly through the cytokines they induce. As epithelial cell TSLP
expression can be regulated by both external and host-derived stimuli, it will be
important to determine the overriding factors that regulate intestinal TSLP expression
both in the steady state and in the case of disease. Not withstanding this, the high levels
of basal expression and the extensive distribution pattern of TSLP in the crypts of the
proximal large intestine suggests a possible regulatory function for IEC-derived TSLP in
intestinal immune homeostasis.

Previously, due to the unavailability of reliable reagents to detect TSLPR surface
expression, the ability to identify cellular targets of TSLP was greatly restricted. In vitro
studies relied upon the detection of phenotypic or functional changes in TSLP-treated
purified cell populations. In vivo studies noted alterations in mixed cell populations in the
presence or absence of TSLP, making it difficult to ascertain direct versus secondary
effects. The development of the fluorochrome-conjugated specific anti-TSLPR mAb has
allowed for the detection of TSLPR+ cells directly ex vivo without cell manipulation or
stimulation.
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Consistent with previous literature we found high levels of TSLPR complex expression in
CD11c+ DCs (Park, Martin et al. 2000; Reche, Soumelis et al. 2001; Liu, Soumelis et al.
2007) isolated from the spleen.

Importantly, we were also able to detect TSLPR

complex expression on DCs isolated from GALT tissues (Figure 6), and verify its
functionality (Figure 9), supporting a role for IEC-derived TSLP modulating intestinal DC
function (Rimoldi, Chieppa et al. 2005). However, DCs isolated from the LP, the most
proximal GALT tissue to the IEC-derived TSLP, demonstrated reduced surface
expression of TSLPR (Figure 6A).

Consistent with this, stimulation of BMDCs with

rTSLP also resulted in downregulation of TSLPR (Figure 6E). More studies need to be
conducted to understand if the lower surface expression is a result of receptor
endocytosis following ligand binding or the result of a regulatory mechanism following
stimulation. Conversely, the microenvironment and cytokine milieu of the LP is unique
and distinct from the other tissues sampled and it is possible that other signals are acting
to regulate LP DC TSLPR expression.

Our in vitro BMDC studies examining the regulation of TSLPR-α chain expression
indicate that receptor surface expression can be modulated by a variety of stimuli.
Stimulation with TLR agonists LPS and CpG failed to upregulate TSLPR expression
(Figure 6C) indicating that the TLR signaling pathway may not influence receptor
expression.

However, as TSLP expression is more strongly upregulated by dsRNA

stimulation and TLR3 signaling (Kato, Favoreto et al. 2007), a wider variety of TLR
agonists should be sampled as possible stimuli to regulate TSLPR expression.
Consistent with in vivo infection studies (Humphreys, Xu et al. 2008; Ramalingam,
Pesce et al. 2009), Ag products derived from Trichuris and S. mansoni stimulated a
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small but detectable up regulation of TSLPR expression in BMDCs (Figure 6C). These
results indicate that in situations of infection, pathogens may directly modulate TSLPR
expression. However, as these products remain unfractionated, the actual proteins or
molecules responsible for the upregulation are unknown. Stimulation with the cysteine
protease allergen papain resulted in strong upregulation of TSLPR expression in BMDCs
(Figure 6C). As previous reports have shown papain to also target basophils (Sokol,
Barton et al. 2008; Sokol, Chu et al. 2009), it is possible that papain may also influence
basophil TSLPR expression.

Our BMDC studies also demonstrate that both pro and anti-inflammatory cytokines can
impact surface levels of TSLPR expression. While treatment with IL-4, IL-6, and TGF-β
all resulted in moderate upregulation of TSLPR expression, stimulation with IFN-γ and
IL-10 resulted in the strongest increase in receptor expression (Figure 6D).

These

results indicate that at least in BMDCs, regulation of TSLPR expression is not exclusive
to TH1, TH2, or anti-inflammatory cytokines. As the tested cytokines signal through a
variety of pathways, and multiple JAKs and STATs are involved it remains difficult to
determine the mechanism of regulation. Nevertheless, these findings indicate another
layer of regulation on DC TSLP-TSLPR interactions. Taken together with our in vivo
studies, these results highlight CD11c+ DCs as important cellular targets of TSLP within
the GALT.

TSLP is also able to impact other innate immune cells as both mast cells and basophils
express the TSLPR complex (Figure 7). Mast cells have previously been recognized to
express both chains of the TSLPR complex at the mRNA level and to respond to
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stimulation with TSLP when in the presence of accessory signals such as IL-1β and
TNF-α (Allakhverdi, Comeau et al. 2007).

We confirm mast cell expression of the

TSLPR complex and also show that basophils express TSLPR (Figure 7).

Further,

administration of rTSLP resulted in a selective increase in frequencies of basophils, but
not mast cells in the spleen and the blood (Figure 7) (Perrigoue, Saenz et al. 2009). The
mechanism responsible for the increased accumulation of basophils remains unclear.
TSLP may be acting to increase basophil survival in the periphery or to increase
basophil release from the bone marrow. While it remains unknown if TSLP is directly
signaling on basophils or is acting through an accessory cell population, expansion of
the basophil population indicates a potential mechanism for TSLP to influence innate
immune responses.

As both mast cells and basophils are known to be important

effectors in TH2 cytokine-mediated inflammation and immune responses (Galli 2000;
Galli, Kalesnikoff et al. 2005; Min 2008; Min and Paul 2008) and TSLP is known to
promote TH2 cytokine-mediated inflammation (Liu 2006; Liu, Soumelis et al. 2007), TSLP
may in part be acting through the activation or recruitment of these cell populations.
Importantly, in situations of overexpression, TSLP has been shown to promote TH2
cytokine-mediated in the absence of T or T and B cells (Yoo, Omori et al. 2005; Li,
Hener et al. 2006).

Collectively, these findings implicate basophils and mast cells as

relevant in vivo cellular targets of TSLP that must taken into account when analyzing the
impact of TSLP-TSLPR interactions on innate and adaptive immunity.

TSLP

has

been

demonstrated

to

act

on

CD4+

T

cells

in

vitro

following

stimulation/activation (Omori and Ziegler 2007; Rochman, Watanabe et al. 2007; Lu,
Wang et al. 2009). Our findings suggest that CD4+ T cells isolated from the spleen and
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GALT express both chains of the TSLPR complex under steady state conditions in vivo
(Figure 8) and can also respond directly ex vivo to stimulation with rTSLP (Figure 9).
These results indicate that in addition to potentially influencing activated CD4+ T effector
cells during an immune response; TSLP may also directly act on CD4+ T cells during
homeostatic conditions. While the contribution of TSLP signaling on CD4+ T cells in vivo
remains unknown, the ability of TSLP to directly influence T cell function must be
recognized and accounted for in future experiments.

Overall, these data indicate that within the intestinal immune system, IEC-derived TSLP
maintains the ability to target and impact cellular components of both the innate and
adaptive immune response. Thus, the TSLP-TSLPR interactions in the GALT represent
a complex network with many potential players.
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CHAPTER 3: TSLP is required for immunity to Trichuris muris, however
TSLP independent TH2 cytokine dependent immune responses can develop
in the absence of IFN-γ

Abstract
Intestinal epithelial cells (IECs) produce thymic stromal lymphopoietin (TSLP), however
the in vivo influence of TSLP-TSLP receptor (TSLPR) interactions on immunity and
inflammation in the intestine remains unclear.

Here we show that TSLP-TSLPR

interactions are critical for immunity to the intestinal pathogen Trichuris. Monoclonal
antibody-mediated neutralization of TSLP or deletion of the TSLPR in normally resistant
mice resulted in defective expression of TH2 cytokines and persistent infection.
Susceptibility was accompanied by elevated production of IFN-γ and IL-17A and the
development of severe intestinal inflammation.

Critically, neutralization of IFN-γ in

Trichuris-infected TSLPR-/- mice restored TH2 cytokine responses and resulted in worm
expulsion, providing the first demonstration of TSLPR-independent pathways for TH2
cytokine production.
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Introduction
Originally characterized as a B cell growth factor, TSLP is now known for its ability to
promote TH2 cytokine responses both in vitro and in vivo. Clinically, TSLP has been
linked to the TH2 cytokine-mediated pathologies of atopic dermatitis and asthma. Skin
biopsies from atopic dermatitis lesions showed greatly enhanced levels of TSLP
compared with non-lesion biopsies (Soumelis, Reche et al. 2002), and heightened TSLP
expression was detected in the airways of asthmatic patients and correlated with
disease severity (Ying, O'Connor et al. 2005).

In vitro studies demonstrated that TSLP-conditioned human DCs can promote TH2 cell
responses (Soumelis, Reche et al. 2002; Al-Shami, Spolski et al. 2005; Ito, Wang et al.
2005; Rimoldi, Chieppa et al. 2005). Mechanistically, TSLP treatment of DCs induces
TH2 cell differentiation by inhibiting IL-12 production while simultaneously inducing
OX40L expression (Ito, Wang et al. 2005; Rimoldi, Chieppa et al. 2005; Liu 2007). The
in vivo functions of TSLP have been most extensively studied in the skin and the lung
(Soumelis, Reche et al. 2002; Al-Shami, Spolski et al. 2005; Yoo, Omori et al. 2005;
Zhou, Comeau et al. 2005). Transgenic over-expression of TSLP in cutaneous or
pulmonary epithelial cells results in the onset of TH2 cytokine-mediated inflammation
resembling atopic dermatitis or asthma respectively (Yoo, Omori et al. 2005; Zhou,
Comeau et al. 2005). Based on these studies it has been proposed that TSLP is both
necessary and sufficient for the initiation of TH2 cytokine-driven inflammation (Liu 2006;
Ziegler and Liu 2006; Liu, Soumelis et al. 2007).
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While TSLP is clearly linked to the promotion of pathogenic TH2 cytokine-mediated
immune responses in the skin and the lung, the role for TSLP in the intestine remains
less defined. Expression of TSLP under steady state conditions has been shown to be
important in maintaining intestinal immune hyporesponsiveness (Rimoldi, Chieppa et al.
2005).

Additionally, we recently showed that TSLP responsiveness is an important

component of early immunity to the intestinal nematode pathogen Trichuris (Zaph, Troy
et al. 2007). However, the mechanisms and absolute requirements for TSLP-TSLPR
interactions in the regulation of intestinal immunity and inflammation in vivo remain
unknown.

In this chapter we characterize the role of TSLP-TSLPR interactions in

immunity to Trichuris infection. We demonstrate that in the absence of TSLP-TSLPR
interactions mice become susceptible to infection and develop severe infection-induced
inflammation accompanied by increased production of proinflammatory cytokines.
However, in the absence of IFN-γ, TSLP is not required for resistance to Trichuris,
indicating TSLP-independent TH2 cytokine responses in the intestine.
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Materials and Methods
Animals
Wild type C57BL/6J transgenic mice were obtained from Jackson Laboratories (Bar
Harbor, ME). TSLPR+/+ and TSLPR-/- mice were obtained from Dr. James Ihle at St.
Jude’s Children’s Hospital, Nashville TN. Mice were bred and maintained in a specificpathogen free environment at the University of Pennsylvania. Animal protocols were
approved by the University of Pennsylvania Institutional Animal Care and Use
Committee (IACUC) and all experiments were carried out following the guidelines of the
University of Pennsylvania IACUC.

Parasites and antigens
Trichuris muris was maintained in genetically susceptible animals (Wakelin 1967;
Wakelin 1969); isolation of Trichuris excretory-secretory (ES) antigen (Ag) and eggs was
carried out as previously described (Artis, Villarino et al. 2004). Mice were infected on
day 0 with 150-200 embryonated eggs and parasite burdens were assessed at various
time points following infection. Serum was analyzed by ELISA for Trichuris-specific
IgG2a as previously described (Artis, Shapira et al. 2002).

Cytokines and monoclonal antibodies
Neutralizing monoclonal antibody against IFN-γ (XMG-6) was purified from ascites by
ammonium sulfate precipitation and dialyzed against PBS. Mice were injected i.p. with 1
mg antibody at the time of infection and every five days post-infection. Neutralizing
monoclonal antibody against murine TSLP (M702) was obtained from Amgen.
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Mice

were injected i.p. with 1 mg antibody at the time of infection and every five days postinfection.

Isolation of cells and flow cytometry staining
At necropsy, MLN were harvested and single-cell suspensions were prepared in DMEM
supplemented with 10% heat-inactivated FBS, 2mM glutamine, 100 U/ml penicillin, 100
µg/ml streptomycin, 25mM HEPES, and 5 x 10-5 M 2-ME.

A portion of cells was

analyzed ex vivo for cytokine production by stimulating with 10 µg/ml brefeldin A, 50
ng/ml PMA, and 750 ng/ml ionomycin for 4-5 h. For DC experiments, MLN cells were
restimulated in the presence of T. muris ES antigen (50 µg/ml) and BFA (10 µg/ml).
Cells were then harvested and stained with fluorochrome-conjugated antibodies against
CD4, IFN-γ, IL-13, CD11c, CD8α, CD11b, TNF-α and IL-12/23p40. Cells were analyzed
by flow cytometry on a FACScalibur using CellQuest Pro software (BD Pharmingen);
further analysis was then carried out using FlowJo software (Treestar, Inc.). MLN cells
were restimulated by plating cells in medium alone, in the presence of T. muris ES Ag
(50 µg/ml), or with 1 µg/ml each of soluble α-CD3 and α-CD28 antibodies. Following 72
h in culture, cells were stimulated with PMA and ionomycin in the presence of brefeldin A
for 4-5 h.

Cell-free supernatants were then harvested and analyzed for cytokine

secretion by sandwich ELISA (eBioscience, San Diego, CA).

The cells were then

harvested and analyzed for cytokine production as described for the ex vivo analysis.

Tissue staining and RELMβ responses
At necropsy, cecal sections were removed and fixed in 4% paraformaldehyde or snapfrozen in OCT medium (Tissue Tek, Sakura Inc.). 5 µm paraffin-embedded sections
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were cut and stained with H&E, PAS/Alcian Blue, or by IF for RELMβ and GOB5 for
visualization of goblet cell responses.

IF staining was carried out as previously

described (Zaph, Troy et al. 2007). Fecal protein isolation was performed as previously
described (Artis, Wang et al. 2004). Samples were equalized by protein content and
analyzed by SDS-PAGE and then immunoblotted for RELMβ using a polyclonal rabbit αmurine RELMβ antibody (Peprotech, Rocky Hill, NJ).

RNA isolation and real-time PCR
RNA was isolated from intestinal tissues of mice using a Trizol extraction and from
BMDCs using RNEasy Spin Columns (Qiagen). Tissues were first disrupted in a tissue
homogenizer (TissueLyzer, Qiagen).

cDNA was synthesized from the isolated RNA

using Superscript Reverse Transcriptase (Invitrogen). Quantitative real-time PCR was
carried out on cDNA samples using commercial primer sets (Qiagen) and SYBR Green
chemistry. All reactions were run on an ABI 7500 Fast Real-Time PCR System (Applied
Biosystems). Samples are normalized to naïve controls unless otherwise stated.
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Results
In vivo neutralization of TSLP in WT mice results in susceptibility to Trichuris
Challenge of genetically resistant mice with the intestinal nematode pathogen Trichuris
results in the dynamic upregulation of TSLP mRNA in the large intestine early during
infection (Humphreys, Xu et al. 2008). Further, we recently demonstrated that in the
absence of the TSLP receptor, genetically resistant mice show an early defect in the
clearance of Trichuris (Zaph, Troy et al. 2007). However, TSLP has been shown to
influence lymphocyte development both in vivo and in vitro (Levin, Koelling et al. 1999;
Sims, Williams et al. 2000; Chappaz, Flueck et al. 2007) and previous work has
established that alterations in the circulating levels of TSLP can influence the frequency
and composition of B cell populations in vivo (Astrakhan, Omori et al. 2007).

To

investigate whether the impaired early immunity to infection in the TSLPR-/- mice was
due to alterations in immune cell development or a definitive requirement for TSLP in
protective immunity, we neutralized endogenous TSLP in genetically resistant animals
during Trichuris infection using a neutralizing anti-TSLP monoclonal antibody (mAb).
While mesenteric lymph node (MLN) cells isolated from control treated WT mice at day
21 post-infection produced IL-4 and IL-13 following antigen-specific restimulation, MLN
cells isolated from anti-TSLP mAb-treated mice exhibited significantly reduced
expression of these cytokines (Figure 10A).

Consistent with a defect in TH2 cell

differentiation in vivo, the frequency of IL-13+ CD4+ T cells was lower in MLN isolated
from anti-TSLP mAb-treated than in control-treated mice (Figure 10B). Expression of
TH2 cytokines in the intestine leads to physiological changes in the intestinal epithelium
including increased cell turnover, goblet cell hyperplasia, and the elevated expression of
goblet cell-associated genes that are correlated with worm expulsion (Theodoropoulos,
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Hicks et al. 2001; Artis, Wang et al. 2004; Artis 2006; Nair, Guild et al. 2006; Wilson,
Zaph et al. 2006; Zaph, Rook et al. 2006; Anthony, Rutitzky et al. 2007). Histological
examination of ceca isolated from infected WT animals revealed goblet cell hyperplasia
and increased mucin staining, consistent with the presence of TH2 cytokines (Figure
10C). In contrast, mucin staining of cecal tissue sections from anti-TSLP mAb-treated
mice failed to show detectable goblet cell responses (Figure 10C). Expression of the
goblet cell-specific proteins RELMβ and GOB5 were also decreased in the anti-TSLP
mAb treated mice (Figure 10D). Further, RELMβ secretion, as determined by protein
analysis of fecal samples, was also defective in infected mice treated with anti-TSLP
mAb (Figure 10E). Consistent with these defective TH2 cytokine responses, anti-TSLP
mAb treated mice failed to exhibit worm expulsion at day 21 post-infection (Figure 10F).
These results show that optimal expression of TSLP is critical for the development of
pathogen-specific TH2 cytokine responses and early immunity to Trichuris.
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Figure 10 In vivo neutralization of TSLP in WT mice results in susceptibility to
Trichuris muris
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Figure 10 In vivo neutralization of TSLP in WT mice results in susceptibility to
Trichuris muris

Figure 10. In vivo neutralization of TSLP in WT mice results in susceptibility to
Trichuris. (A) Antigen-specific cytokine production from restimulated MLN cells
was determined by ELISA. (B) Frequencies of CD4+ IL-13+ T cells in the MLN
following 72h Ag restimulation. Plots are gated on CD4+ T cells. (C - E) AntiTSLP treated mice fail to induce goblet cell responses following infection. (C)
Paraffin sections of cecal tissue were stained with PAS/Alcian blue for goblet cell
visualization. (D) Paraffin sections of cecal tissue were IF stained for RELMβ and
GOB5 (green) and co-stained with DAPI (blue). (E) Protein isolated from fecal
pellets on various days post infection was analyzed by SDS-PAGE and
immunoblotted for RELMβ, N – naïve, uninfected control. (F) Worm burdens were
assessed at day 21 post-infection. Bar, 50 µm. Error bars indicate s.e.m. Data
represents three individual experiments with 3-6 mice per group.
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TSLP-TSLPR interactions are critical for immunity to Trichuris
Deletion of TSLPR in normally resistant mice resulted in increased IFN-γ production and
elevated worm burdens at day 21 post-infection (Zaph, Troy et al. 2007).

In genetically

resistant strains of mice, CD4+ TH2 cell-mediated expulsion of Trichuris occurs between
days 18-21 while genetically susceptible mice develop persistent infection and retain
parasites for the lifetime of the host (Else, Finkelman et al. 1994). However, impaired
early worm expulsion is not always indicative of a failed host-protective response. For
example, Trichuris-infected mice deficient in ICOS fail to expel worms at day 18 postinfection but are able to successfully mount a protective TH2 cytokine-mediated response
and clear infection by day 34 post-infection (Wilson, Zaph et al. 2006). Thus TSLPTSLPR interactions could be required for optimal early TH2 cytokine responses but not
for subsequent TH2 cell-mediated clearance of infection.

To determine whether blockade of the TSLP-TSLPR pathway resulted in persistent
chronic infection or simply resulted in delayed worm expulsion, TSLPR+/+ and TSLPR-/mice were infected with Trichuris and the kinetics of worm expulsion were monitored
over 34 days.

MLN cells isolated from infected TSLPR-/- mice failed to produce

detectable levels of TH2 cytokines (Figure 11A).

Histological examination of cecal

sections also revealed defective TH2 cytokine-dependent goblet cell hyperplasia in
infected TSLPR-/- mice in comparison to infected TSLPR+/+ mice (Figure 11B). Further,
production of goblet cell-derived RELMβ and GOB5 was decreased in infected TSLPR-/mice compared to infected TSLPR+/+ mice (Figure 11C). Luminal secretion of RELMβ
was also decreased and unsustained in infected TSLPR-/- mice (Figure 11D).

The

defective TH2 cytokine responses functionally altered the outcome of infection, as
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TSLPR-/- mice failed to mediate worm expulsion even at a late time points and remained
heavily infected at day 34 post-infection (Figure 11E). In addition, chronic infection was
also observed in WT mice treated with anti-TSLP mAb as they exhibited high worm
burdens at day 34 post-infection (Figure 12). Taken together, neutralization of TSLP
and deletion of the TSLPR identify a critical role for TSLP-TSLPR interactions in the
development of a host protective TH2 cytokine-dependent immune response to Trichuris.
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Figure 11 TSLP-TSLPR interactions are critical for immunity to Trichuris muris

Figure 11. TSLP responsiveness is required for immunity to Trichuris muris. (A)
TSLPR-/- mice are unable to induce TH2 cytokine production. Antigen-specific
cytokine production from restimulated MLN cells was determined by ELISA. (B - D)
TSLPR-/- mice have decreased goblet cell responses. (B) Cecal sections from
TSLPR+/+ or TSLPR-/- mice were taken at day 20 post-infection and stained
PAS/Alcian blue. (C) Paraffin sections of cecal tissue were IF stained for RELMβ
and GOB5 (green) and co-stained with DAPI (blue). (D) Protein isolated from fecal
pellets on various days post infection was analyzed by SDS-PAGE and
immunoblotted for RELMβ. (E) Worm burdens in TSLPR+/+ and TSLPR-/- mice
were assessed at days 20 and 34 post-infection. Bar, 50 µm. Error bars indicate
s.e.m. Data represents three individual experiments with 3-4 mice per group.
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Figure 12 Anti-TSLP treatment in WT mice results in chronic infection

Figure 12. In vivo depletion of TSLP in WT mice results in chronic Trichuris
infection. Worm burdens were assessed at day 34 post-infection. Error bars
indicate s.e.m. Results are representative of two individual experiments with 3-4
mice per group.
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Increased

infection-induced

inflammation

and

proinflammatory

cytokine

production in the absence of TSLP-TSLPR interactions
The defective production of TH2 cytokines and susceptibility to Trichuris following the
disruption of the TSLP-TSLPR pathway could be the result of impaired responsiveness
to infection or dysregulation of T helper cell responses.

Histological examination of

cecal sections taken at day 34 post-infection revealed immune-mediated alterations in
both WT and TSLPR-/- mice (Figure 13A).

Cecal sections from WT mice exhibited

minimal to mild submucosal edema, mixed inflammatory cell infiltrate and mild crypt
hyperplasia indicative of a recent infection. In contrast, TSLPR-/- mice exhibited severe
infection-induced inflammation characterized by severe submucosal edema and
transmural inflammation with lymphocytic infiltrate in the muscularis and mixed
lymphocytic and neutrophilic infiltrate in the submucosa and lamina propria (Figure 13A).
Additionally, IECs in the TSLPR-/- mice appeared activated, and numerous mitotic figures
were observed (Figure 13B, arrows). TSLPR-/- mice also exhibited foci of inflammation
with disruption of crypt architecture (Figure 13C). Depletion of TSLP in WT mice also
resulted in severe-infection induced inflammation. Histological examination of day 34
post-infection cecal sections showed severe submucosal edema and transmural
inflammation in the anti-TSLP treated mice, but not the WT mice (Figure 14 A, B).
Further, anti-TSLP mice exhibited foci of inflammation (Figure 14 C, left panel) and
immune cell infiltration in between the crypts (Figure 14 C, right panel), both of which
were absent in WT mice (Figure 14 B).

The severe infection-induced inflammation

exhibited in the absence of TSLP-TSLPR interactions contrasts with the mild to
moderate inflammation seen in genetically susceptible AKR mice that also exhibit
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chronic infection (Artis, Humphreys et al. 1999; Bancroft, Artis et al. 2000; Owyang,
Zaph et al. 2006).

The presence of severe intestinal inflammation in the TSLPR-/- mice suggested that
susceptibility to Trichuris was not solely due to a lack of TH2 responsiveness, but
involved a more general dysregulation of infection-induced innate and adaptive immune
responses.

Consistent with this hypothesis, there was a significant increase in the

frequency of CD4+ IFN-γ+ T cells isolated from the MLN of TSLPR-/- mice at day 21 postinfection compared to WT mice (Figure 13D). Restimulated MLN cells isolated from
infected TSLPR-/- mice exhibited significantly elevated production of IFN-γ and IL-17A in
comparison to infected WT mice following either antigen-specific or polyclonal
stimulation (Figure 13E, F).

As anti-TSLP treated WT mice also developed severe

infection-induced inflammation, we investigated proinflammatory cytokine production in
these mice. Similar to the findings with the TSLPR-/- mice, increased frequencies of
CD4+ IFN-γ+ T cells were detected in MLNs isolated from anti-TSLP treated WT mice
compared to WT control mice at day 21 post-infection (Figure 15A). MLN cells from antiTSLP treated mice also produced significantly increased levels of IFN-γ compared to WT
mice following Ag-specific restimulation (Figure 15B). Consistent with the upregulation of
IFN-γ protein, anti-TSLP treated mice also exhibited increased levels of IFN-γ mRNA in
the MLN compared to controls (Figure 15C). Also, isolation of RNA from large intestine
tissue samples revealed a trend towards increased levels of IL-17A mRNA in the antiTSLP treated mice compared to WT mice (Figure 15D). Dysregulated proinflammatory
cytokine expression persisted in chronic infection, as infected TSLPR-/- mice showed
increased frequencies of CD4+ IFN-γ+ T cells in MLN compared to WT mice at day 34
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post-infection (Figure 16). The heightened expression of IFN-γ and IL-17A and severe
intestinal inflammation exhibited upon disruption of the TSLP-TSLPR pathway
demonstrates that susceptibility to infection is not solely due the impairment of TH2
cytokine responses but also due to the development of an unregulated proinflammatory
cytokine response.
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Figure 13 TSLPR-/- mice have increased infection-induced inflammation and
proinflammatory cytokine production

Figure 13. TSLP-TSLR interactions limit proinflammatory cytokine production and
infection-induced inflammation. (A-C) TSLPR-/- mice have increased infectioninduced inflammation.
Paraffin-embedded cecal sections from day 34 postinfection were stained with H&E. (B) Epithelial cells in TSLPR-/- mice exhibit
numerous mitotic figures (arrowheads). (C) TSLPR-/- mice exhibit foci of
inflammation with loss of crypt architecture. (D-G) TSLPR-/- mice have increased
proinflammatory cytokine production at day 20 post-infection. (D) Frequencies of
CD4+ IFN-γ+ T cells in the MLN at day 20 post-infection. (E) Antigen-specific IFN-γ
production from restimulated MLN was determined by ELISA. (F) Polyclonal IL17A production from restimulated MLN was determined by ELISA. Error bars
indicate s.e.m. Data represent two to three individual experiments with 3-4 mice
per group.
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Figure 14 Anti-TSLP treatment in WT mice results in increased infection-induced
inflammation

Figure 14. Depletion of TSLP in Trichuris infected WT mice results in infectioninduced inflammation. Paraffin-embedded cecal sections from day 34 postinfection were stained with H&E. (A). Anti-TSLP mAb-treated mice displayed
severe submucosal edema with mixed inflammatory cell infiltrate. Second panel
represents a greater magnification of boxed areas in first panel. (B) Increased
magnification of a representative cecal section from WT mice showing minimal
submucosal edema. (C ) Increased magnification of representative cecal cross
sections of anti-TSLP treated mice. Sections show foci of inflammation (left panel)
and lymphocytic infiltration between crypts (right). Bar, 50 µm. Results are
representative of two individual experiments with 3-4 mice per group.
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Figure 15 Anti-TSLP treatment in WT mice results in increased proinflammatory
cytokine production

Figure 15. Depletion of TSLP in Trichuris infected WT mice results in increased
expression of IFN-γ and IL-17. (A) Anti-TSLP mAb treated mice have increased
frequencies of CD4+ IFN-γ+ T cells in the MLN at day 21 post-infection. Plots are
gated on CD4+ cells. (B) Antigen-specific IFN-γ from restimulated MLN cells by
ELISA. (C) Anti-TSLP mAb treated mice have increased mRNA transcripts for IFNγ in the MLN at day 21-post infection. (D) Anti-TSLP mAb treated mice have
increased mRNA transcript for IL-17A in the large intestine at day 34 postinfection. Error bars indicate s.e.m. Results are representative of three individual
experiments with 3-6 mice per group.
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Figure 16 TSLPR-/- mice exhibit elevated frequencies of CD4+ IFN-γ + T cells in the
MLN at day 34 post-infection

Figure 16. Infected TSLPR-/- mice have increased frequencies of CD4+ IFN-γ+ T
cells in the MLN at day 34 post-infection. Plots are gated on CD4+ cells. Results
are representative of three individual experiments with 3-4 mice per group.
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TSLP is not required to initiate TH2 cytokine responses in the intestine
Previous studies in both skin and lung models of TH2 cytokine-mediated allergic
inflammation indicated that TSLP is both necessary and sufficient to drive the
development of TH2 cytokine-dependent inflammation, suggesting that TSLP may be a
‘master switch’ for the development of TH2 cytokine responses (Yoo, Omori et al. 2005;
Zhou, Comeau et al. 2005; Liu 2006). The impaired immunity to Trichuris exhibited
following disruption of the TSLP-TSLPR pathway supports this model. However, antiTSLP mAb treatment or deletion of TSLPR resulted in heightened CD4+ T cell-derived
IFN-γ production. To test whether TSLP-TSLPR interactions were absolutely required or
dispensable for Trichuris-induced TH2 cytokine responses, Trichuris-infected TSLPR-/mice were treated with neutralizing monoclonal antibodies against IFN-γ throughout the
course of infection.

If TSLP-TSLPR interactions were necessary for TH2 cytokine

responses, anti-IFN-γ treated TSLPR-/- mice would remain susceptible to Trichuris.

Following neutralization of IFN-γ in infected TSLPR-/- mice there was a marked reduction
in the frequency of IFN-γ+ CD4+ T cells in the MLN at day 21 post-infection compared to
control treated TSLPR-/- mice, consistent with the role of IFN-γ in promoting TH1
responses (Figure 17A).

Coincident with decreased levels of IFN-γ there was an

increase in levels of IL-4, IL-5, and IL-13 secreted from antigen-restimulated MLN cells
from anti-IFN-γ treated TSLPR-/- mice compared to the control treated TSLPR-/- mice
(Figure 17B).

Critically, the levels of IL-4, IL-5, and IL-13 in the anti-IFN-γ treated

TSLPR-/- mice were comparable to those seen in resistant TSLPR+/+ mice (Figure 17B).
Blockade of IFN-γ did not impact Trichuris-specific IgG1 serum antibody levels (data not
shown), but did inhibit the development of a Trichuris-specific IgG2a serum antibody
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response, as serum levels of IgG2a in anti-IFN-γ treated TSLPR-/- mice were comparable
to levels in TSLPR+/+ mice (Figure 17C). Goblet cell responses were restored as the
expression of both GOB5 and RELMβ were increased in anti-IFN-γ treated TSLPR-/mice (Figure 17D,E). Further, histological examination revealed that the severe crypt
elongation, edema and inflammatory infiltrate present in the Trichuris-infected TSLPR-/mice were absent following anti-IFN-γ treatment (Figure 17F). Critically, anti-IFN-γ
treatment also recovered immunity in the TSLPR-/- mice. While control treated TSLPR-/mice exhibited persistent infection, anti-IFN-γ treated mice exhibited reduced worm
burdens at day 21 post-infection with subsequent worm expulsion and clearance by day
34 post-infection (Figure 17G). The delay in worm clearance from day 21 to day 34
post-infection in the anti-IFN-γ treated TSLPR-/- mice indicates that while TSLP-TSLPR
interactions are not required for immunity, they may play an important role in the
development of optimal protective immune responses following Trichuris infection. AntiIFN-γ treatment also augmented levels of total serum IgE (Figure 18). These results
demonstrate that in the absence of IFN-γ in an in vivo system, TSLP-independent
mechanisms allow for the generation of a protective TH2 cytokine response in the
intestine.
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Figure 17 Neutralization of IFN-γ in susceptible TSLPR-/- mice restores TH2
cytokine production and immunity
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Figure 17 Neutralization of IFN-γ in susceptible TSLPR-/- mice resotres TH2
cytokine production and immunity

Figure 17. TSLP is not required for the initiation of an intestinal TH2 cytokine
response to Trichuris. (A) Frequencies of CD4+ IFN-γ+ T cells isolated from the
MLN and stimulated directly ex vivo. (B) Antigen-specific cytokine production from
restimulated MLN cells was determined by ELISA. (C) Antigen-specific serum
IgG2a levels. (D, E) Antibody treatment restored goblet cell function in TSLPR-/mice. (D) Protein isolated from fecal pellets on various days post infection was
analyzed by SDS-PAGE and immunoblotted for RELMβ. (E) Paraffin sections of
cecal tissue were IF stained for RELMβ and GOB5 (green) and co-stained with
DAPI (blue). (F) Day 34 cecal sections were stained with H&E. (G) Worm burdens
were assessed at days 21 and 34 post-infection. Bars, 50 µm. Error bars indicate
s.e.m. Data are representative of two individual experiments with 3-4 mice per
group.
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Figure 18 Anti-IFN-γ treatment increases serum IgE levels

Figure 18. Anti-IFN-γ treatment of Trichuris-infected TSLPR-/- mice increases total
serum IgE levels at day 21 post-infection. Error bars indicate s.e.m. Data is
representative of two individual experiments with 3-4 mice per group.
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Discussion
These findings indicate a key role for TSLP-TSLPR interactions in regulating intestinal
immunity and inflammation. We show for the first time that the TSLP-TSLPR pathway
within the intestine is critical for host-protective immunity, as disruption of TSLP-TSLPR
interactions in vivo led to susceptibility to Trichuris infection. Following infection, antiTSLP mAb-treated WT mice and TSLPR-/- mice remained chronically infected, had
elevated expression of IFN-γ and IL-17A, and exhibited severe infection-induced
inflammation. However, unlike models of inflammation in the skin or the lung, we found
that TSLP was not critically required for pathogen-specific TH2 cytokine responses in the
intestine.

Infected TSLPR-/- mice treated with neutralizing anti-IFN-γ antibodies

recovered pathogen-specific TH2 cytokine production and immunity, thus identifying
TSLP-independent pathways for the initiation of intestinal TH2 cytokine responses.

The putative link between TSLP and the promotion of TH2 cytokine responses has been
well developed in both in vitro and in vivo studies (Liu 2006; Ziegler and Liu 2006; Liu,
Soumelis et al. 2007). Initial in vitro studies found that human monocyte-derived DCs
treated with TSLP induced CD4+ T cells to produce IL-4 upon co-culture (Soumelis,
Reche et al. 2002; Al-Shami, Spolski et al. 2005; Rimoldi, Chieppa et al. 2005), and that
TSLP-induced upregulation of OX40L on DCs promoted CD4+ TH2 cell differentiation
(Ito, Wang et al. 2005). Recent work also demonstrated the ability of TSLP to directly
influence both human and murine CD4+ T cells (Omori and Ziegler 2007; Rochman,
Spolski et al. 2009). In the murine system, in vitro treatment of purified CD4+ T cells with
TSLP induced T cell IL-4 production and TH2 cell (Omori and Ziegler 2007). Further, in
the presence of TNF-α or IL-1, TSLP has been shown to induce production of the TH2
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cytokines IL-5 and IL-13 from mast cells (Allakhverdi, Comeau et al. 2007). Supporting
these in vitro studies, the transgenic over-expression of TSLP by epithelial cells in the
skin or the lung induces TH2 cytokine-mediated inflammation in vivo (Yoo, Omori et al.
2005; Zhou, Comeau et al. 2005). Thus, through its ability to influence both innate cell
populations as well as CD4+ T cells, TSLP could contribute both directly and indirectly to
TH2 cell differentiation in vivo.

TSLP may act to directly influence TH2 cell differentiation by directly influencing CD4+ T
cell cytokine production.

For example, TSLP has been shown to promote il-4 gene

transcription in CD4+ T cells (Omori and Ziegler 2007). While the exact mechanisms
remain unknown, it is possible that TSLP-induced STAT5 activation plays a role in
promoting Il-4 gene transcription independently of IL-4, STAT6, or GATA-3 (Zhu, CoteSierra et al. 2003; Takatori, Nakajima et al. 2005; Zhu, Yamane et al. 2006). Once
transcription is initiated, IL-4 may act in an autocrine fashion on CD4+ T cell to activate
STAT6 and upregulate GATA-3 expression, promoting and stabilizing TH2 cell
differentiation (Murphy and Reiner 2002; Mowen and Glimcher 2004).

Indirectly, TSLP could promote TH2 cell differentiation by influencing innate cell
responses. TSLP may induce mast cell production of IL-13, which could signal through
STAT6 to promote proximal events including GATA-3 upregulation in TH2 cell
differentiation (Murphy and Reiner 2002; Mowen and Glimcher 2004).

Additionally,

administration of rTSLP elicits increased frequencies of basophils (Chapter 2 and
(Perrigoue, Saenz et al. 2009)), and basophils have recently been demonstrated to be
important antigen presenting cells in the initiation of TH2 cytokine immune responses
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(Perrigoue, Saenz et al. 2009; Sokol, Chu et al. 2009; Yoshimoto, Yasuda et al. 2009).
Neither of these possibilities is mutually exclusive however, and it is likely that TSLP acts
through multiple pathways to promote TH2 cell differentiation and TH2 cytokine
production.

Beyond an influence on TH2 cytokine production, TSLP may also regulate recruitment
and/or retention of immune cells at the site of infection or inflammation. For example,
TSLP treatment of human mDCs induces expression of the chemokines CCL17 and
CCL22, known ligands for CCR4, a chemokine receptor found on effector TH2 cells
(Soumelis, Reche et al. 2002; Liu 2006). Thus following exposure to Trichuris, IECderived TSLP could be acting on intestinal DCs to simultaneously create conditions
permissive to TH2 cell differentiation and to promote TH2 effector cell recruitment or
retention in the intestine.

While these data support a role for TSLP in directly influencing and promoting TH2
cytokine responses, our finding that TSLP was not critically required for the initiation of a
pathogen-specific TH2 cytokine response following Trichuris infection demonstrates that
there are TSLP-independent pathways for the generation of intestinal TH2 cytokine
responses.

In the absence of TSLP it is possible that a combination of other TH2-

promoting factors present in the intestine is able to compensate and either act alone or
in concert to create a microenvironment permissive for TH2 cell differentiation.
Candidates include cytokines such as IL-25 and IL-33 as they have each been
demonstrated to promote TH2 cytokine responses (Fort, Cheung et al. 2001; Schmitz,
Owyang et al. 2005). Further, both IL-25 and IL-33 have been shown to play important
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roles in immunity to Trichuris infection (Owyang, Zaph et al. 2006; Humphreys, Xu et al.
2008; Saenz 2008).

The Notch-Notch ligand pathway may also play a role in the

generation of TSLP-independent TH2 cytokine responses in the intestine. Previous work
has demonstrated that Notch-Notch ligand interactions are important in mediating
immunity to Trichuris (Tu, Fang et al. 2005), and Notch may act either directly in the
promotion of TH2 cell differentiation (Ansel, Djuretic et al. 2006; Amsen, Antov et al.
2007; Fang, Yashiro-Ohtani et al. 2007; Kubo 2007; Perrigoue, Marshall et al. 2008) or
through its influence on epithelial cell function (Demehri, Liu et al. 2008). Thus, TSLP
may be another factor that, while not itself essential for the development of TH2 cytokine
responses in the intestine, is critical in combination with a number of other factors to
create a TH2 permissive microenvironment. Additionally, as anti-IFN-γ treated TSLPR-/mice displayed delayed worm clearance during Trichuris infection, TSLP-TSLPR
interactions may also be important in determining the magnitude and/or kinetics of TH2
cytokine responses in the intestine. As TSLP does not appear to be strictly required for
intestinal TH2 cytokine responses, and loss of TSLP-TSLPR interactions resulted in
increased infection-induced proinflammatory cytokine production and inflammation, it is
possible that TSLP may also have another regulatory role in the intestine.

The

hypothesis that TSLP is important in the regulation of intestinal proinflammatory cytokine
production will be tested in Chapter 4.
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CHAPTER 4: A role for TSLP-TSLPR interactions in the inhibition of
proinflammatory cytokine production in the intestine

Abstract
The importance of TSLP-TSLPR interactions in the promotion of TH2 cytokine-mediated
inflammation has been well documented and studied. However, we previously
demonstrated that TSLP is not critically required for intestinal TH2 cytokine responses,
and that in the absence of TSLP-TSLPR interactions mice infected with Trichuris exhibit
elevated

proinflammatory

cytokine

inflammation in the large intestine.

production

and

increased

infection-induced

Despite these findings, little is known about the

potential of TSLP-TSLPR interactions to regulate intestinal proinflammatory cytokine
production.

Here, we demonstrate that naïve TSLPR-/- mice have a trend towards

increased frequencies of CD4+ IFN-γ+ T cells in the GALT and intestine compared to
naïve littermate control TSLPR+/+ mice. Introduction of rTSLP into whole splenocyte
cultures was also sufficient to inhibit IFN-γ production from CD4+ T cells in the absence
of IL-4, indicating an IL-4-independent pathway of TSLP-dependent inhibition of IFN-γ
production by CD4+ T cells.

TSLP was found to inhibit DC-derived IL-12/23p40

production both in vitro and in vivo. Additionally, TSLPR-/- mice were found to be more
susceptible to DSS-induced colitis, exhibiting increased proinflammatory cytokine
production and more severe intestinal inflammation compared to DSS-treated WT mice.
Collectively, these findings suggest that TSLP-TSLPR interactions in the GALT play a
previously unrecognized role in the regulation of proinflammatory cytokine production
and inflammation in the intestine.
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Introduction
TSLP-TSLPR interactions maintain the ability to promote TH2 cytokine-mediated immune
responses through a variety of mechanisms. TSLP can influence DC (Soumelis, Reche
et al. 2002; Ito, Wang et al. 2005; Rimoldi, Chieppa et al. 2005; Zaph, Troy et al. 2007),
CD4+ T cell (Omori and Ziegler 2007; Rochman, Watanabe et al. 2007), and mast cell
function (Allakhverdi, Comeau et al. 2007) to promote TH2 cytokine production. As a
result of these diverse abilities, TSLP has been recognized as a critical factor in the
promotion of TH2 cytokine-mediated inflammation in the skin and the lung (Soumelis,
Reche et al. 2002; Al-Shami, Spolski et al. 2005; Yoo, Omori et al. 2005; Zhou, Comeau
et al. 2005; Liu 2006; Liu, Soumelis et al. 2007). Further, TSLP-TSLPR interactions are
important in the development of a host-protective TH2 cytokine response to infection with
intestinal pathogen Trichuris muris (Chapter 3, (Zaph, Troy et al. 2007).

In addition to these functions, there is also evidence to suggest that TSLP may play an
immunoregulatory role in the inhibition of proinflammatory cytokine production within the
intestine. The ability of TSLP to modulate DC production of the TH1 cytokine-promoting
factor IL-12 has been previously documented (Soumelis, Reche et al. 2002; Ito, Wang et
al. 2005; Rimoldi, Chieppa et al. 2005; Zaph, Troy et al. 2007). Within the intestine,
constitutive IEC production of TSLP was found to be important in the maintenance of
intestinal immune hyporesponsiveness through the promotion of TH2 cell differentiation
and the inhibition of IFN-γ production (Rimoldi, Chieppa et al. 2005). Further, disruption
of the TSLP-TSLPR pathway in mice results in increased infection-induced inflammation
and elevated levels of IFN-γ and IL-17A following infection with Trichuris (Chapter 3
(Zaph, Troy et al. 2007)).
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Additionally, while TSLP-TSLPR interactions were critical for the development of a hostprotective TH2 cytokine-mediated immune response to infection with the intestinal
parasite Trichuris, TSLP-independent TH2 cytokine immune responses developed in the
absence of IFN-γ (Chapter 3 (Taylor, Zaph et al. 2009)). TSLP was also not required for
TH2 cytokine-mediated immunity to Heligomosomoides polygyrus and Nippostrongylus
brasiliensis (Massacand, Stettler et al. 2009).

These data indicate that TSLP is not

critically required for the development of intestinal host-protective TH2 cytokine
responses. Taken together with the findings of dysregulated proinflammatory cytokine
production in the absence of TSLP, these data suggest that TSLP may also have a
regulatatory function within the intestine.

In this chapter, we demonstrate dysregulated production of GALT DC-derived IL12/23p40 and CD4+ T cell-derived IFN-γ in naïve TSLPR-/- mice. While this disruption of
intestinal immune homeostasis was not sufficient to result in the development of
spontaneous colitis, TSLPR-/- mice do exhibit increased susceptibility to DSS-induced
colitis. Further, we demonstrate that IEC-derived TSLP regulates DC production of IL12/23p40 both in vitro and in vivo, and that addition of rTSLP into whole splenocyte
cultures is able to inhibit CD4+ T cell production of IFN-γ in the absence of IL-4. As a
whole, these data indicate that in addition to its ability to promote TH2 cytokine
responses, TSLP also acts to limit proinflammatory cytokine production and
inflammation in the intestine.
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Materials and Methods
Animals
Wild type C57BL/6J transgenic mice were obtained from Jackson Laboratories (Bar
Harbor, ME). TSLPR+/+ and TSLPR-/- mice were obtained from Dr. James Ihle at St.
Jude’s Children’s Hospital, Nashville TN. Mice were bred and maintained in a specificpathogen free environment at the University of Pennsylvania. Animal protocols were
approved by the University of Pennsylvania Institutional Animal Care and Use
Committee (IACUC) and all experiments were carried out following the guidelines of the
University of Pennsylvania IACUC.

DSS-induced intestinal inflammation.
DSS (MP Biomedicals) was added to drinking water at 5% weight/volume for four days.
Mice were monitored for weight loss, rectal bleeding and general appearance
(piloerection, lethargy). Pathology was scored as follows: A) Weight loss, No change =
0; <5% = 1; 6–10% = 2; 11–20% = 3; >20% = 4; B) Feces, Normal = 0; Pasty, semiformed = 2; Liquid, sticky or unable to defecate after five minutes = 4; C) Blood, No
blood = 0; Visible blood in rectum = 1; Visible blood on fur = 2; D) General appearance,
Normal = 0; Piloerection = 1; Lethargy and piloerection = 2; Motionless, sickly = 4.

Isolation and preparation of cells
At necropsy, spleen, MLN, cecal patch, peyer’s patch, were harvested and single-cell
suspensions were prepared in complete T cell medium (CTCM) (DMEM supplemented
with 10% heat-inactivated FBS, 2mM glutamine, 100 U/ml penicillin, 100 µg/ml
streptomycin, 25mM HEPES, and 5 x 10-5 M 2-ME).
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If dendritic cells were to be

examined, tissues were first minced and incubated in 5 mls of digestive enzyme solution
(0.5 mg/ml collagenase and 0.05% DNAse in CTCM) for 25 minutes at 37 °C while
shaking prior to the creation of single-cell suspensions.

Isolation of intraepithelial and lamina propria lymphocytes
At necropsy, small intestine and large intestine were removed and put into separate Petri
dishes with pre-warmed CTCM. Cecal patch and Peyer’s patches were removed and
placed in 2 mls CTCM on ice. Intestines were cut longitudinally and feces were removed
by shaking in a large Petri dish of PBS. Intestines were further cleaned and mucus
removed by shaking in a clean Petri dish until PBS remained clear. Intestines were then
cut into small sections and placed in 20 mls prewarmed epithelial strip buffer (1mM
EDTA, 1 mM DTT, 5% fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin)
and incubated for 20 minutes at 37 °C while shaking. Tissue was allowed to settle and
supernatant was filtered through a cell strainer for isolation of intraepithelial lymphocytes
(IELs).

Purification of IELs was conducted though utilization of a Percoll gradient.

Briefly, cells were resuspended in 5 mls of 40% Percoll, underlayed with 70% Percoll,
and the spun for 20 minutes at 600 g with the brake removed. Cells were then pipetted
from the interface and washed twice with CTCM, before resuspending in final volume.
For isolation of lamina propria lymphocytes (LPLs), intestines were washed with serumfree media 3 times, and then minced using a razor blade in a small Petri dish. Intestines
were then resuspended in 15 mls of digestive enzyme solution (0.5 mg/ml collagenase
and 0.05% DNAse in CTCM) and incubated for 30 minutes 37 °C while shaking. The
entire contents of each tube were then filtered through a cell strainer, and intestines
were mashed in the cell strainer using the back end of a 3 ml syringe. The strainers
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were then washed with 15 mls CTCM. Cells were then pelleted and washed with CTCM
before the Percoll purification was preformed as described above.

Flow cytometry and intracellular cytokine staining
A portion of cells was analyzed ex vivo for cytokine production by stimulating with 10
µg/ml brefeldin A, 50 ng/ml PMA, and 750 ng/ml ionomycin for 4-5 h.

For DC

experiments, MLN cells were restimulated in the presence of T. muris ES antigen (50
µg/ml) and BFA (10 µg/ml). Cells were then harvested, washed in PBS and stained with
the fixable aqua blue viability dye (Invitrogen) to assess viability.

Cells were then

stained with fluorochrome-conjugated antibodies against CD3, CD4, IFN-γ, IL-17A, IL10, FoxP3, CD11c, CD8α, CD11b, TNF-α, and IL-12/23p40. Cells were analyzed by
flow cytometry on a FACS Calibur or a FACS CANTOII using CellQuest Pro software
(BD Pharmingen); further analysis was then carried out using FlowJo software (Treestar,
Inc.). MLN cells were restimulated by plating cells in medium alone, in the presence of
T. muris ES Ag (50 µg/ml), or with 1 µg/ml each of soluble α-CD3 and α-CD28
antibodies. Following 72 h in culture, cells were stimulated with PMA and ionomycin in
the presence of brefeldin A for 4-5 h. Cell-free supernatants were then harvested and
analyzed for cytokine secretion by sandwich ELISA (eBioscience, San Diego, CA). The
cells were then harvested and analyzed for cytokine production as described for the ex
vivo analysis.

BMDCs and BMDC: T cell co-culture
Bone marrow derived-dendritic cells (BMDCs) were derived as follows. Bone marrow
from WT C57BL/6 mice was plated in 6 well cell culture plates in RPMI 1640
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supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 5 x 10-5 M 2-ME, 10%
FBS, 2mM L-glutamine, and 20 ng/ml GM-CSF (Peprotech). Media was changed at
days 3, 6 and 8; cells were harvested at day 9. BMDCs were plated out at 4 x 106
cells/ml and mixed 1:1 with either media alone, IEC supernatants (CMT-93 cell line), or
rTSLP (final concentration 10 or 100 ng/ml from R & D), for 16-18 h.
stimulated with LPS (10 ng/ml).

Cells were

At various time points cell-free supernatants were

harvested for analysis by ELISA and cells were harvested either for analysis by flow
cytometry or RT-PCR for mRNA expression. For BMDC: T cell co-culture, BMDCs were
harvested and conditioned with CMT-93 supernatants or rTSLP as described above.
They were then pulsed with 0.5 mg/ml ovalbumin (Worthington) and 1 µg/ml CpG (Coley
Pharmaceutical Group) for 16-18 h. Purified OT-II CD4+ T cells were cultured with the
BMDCs for 4 days. Cells were stimulated with PMA, ionomycin, and brefeldin A for the
final 4 h and analyzed by flow cytometry.

Tissue staining
At necropsy, sections of the proximal large intestine were removed, flushed with PBS,
and fixed in 4% paraformaldehyde. 5 µm paraffin-embedded sections were cut and
stained with H&E.

RNA isolation and real-time PCR
RNA was isolated from intestinal tissues of mice using a Trizol extraction and from
BMDCs using RNEasy Spin Columns (Qiagen). Tissues were first disrupted in a tissue
homogenizer (TissueLyzer, Qiagen).

RNA was extracted from purified cells using

RNeasy spin columns (Qiagen). cDNA was synthesized from the isolated RNA using
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Superscript Reverse Transcriptase (Invitrogen). Quantitative real-time PCR was carried
out on cDNA samples using commercial primer sets (Qiagen) and SYBR Green
chemistry. All reactions were run on an ABI 7500 Fast Real-Time PCR System (Applied
Biosystems). Samples are normalized to naïve controls unless otherwise stated.
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Results
Naïve TSLPR-/- mice exhibit increased frequencies of CD4+ IFN-γ +T cells in the
GALT
The increased levels of IFN-γ and IL-17A seen in TSLPR-/- mice following Trichuris
infection is indicative of dysregulated T helper cell differentiation within the GALT.
Further, IEC-derived TSLP has been previously demonstrated to be important in
maintaining intestinal immune cell homeostasis (Rimoldi, Chieppa et al. 2005).

To

investigate whether TSLPR-/- mice have altered homeostasis of intestinal CD4+ T cells,
cells were isolated from the GALT and large intestine of naïve TSLPR-/- mice and
TSLPR+/+ controls, and examined ex vivo following PMA/Ionomycin stimulation for
cytokine production. As the composition of the commensal bacteria within the intestine
can greatly impact CD4+ IL-17A production (Ivanov, Frutos Rde et al. 2008),
experiments were performed with littermate control mice raised in the same SPF facility.

A trend towards increased frequencies of CD4+ IFN-γ+ T cells was observed in the MLN
and CP of TSLPR-/- mice compared to littermate controls (Figure 19A). This trend was
most apparent in the MLN and was consistent among three individual experiments (p =
0.04, p = 0.06, p = 0.1).

Although individual experiments did not reach statistical

significance in the CP, combined data from 3 experiments representing a total of 10
mice show a trend towards increased frequencies of CD4+ IFN-γ+ T cells in the TSLPR-/mice compared to TSLPR+/+ mice (p = 0.08). While slight increases of CD4+ IFN-γ+ T
cells were observed in the PP and in both the IEL and LPL compartments of the large
intestine lamina propria of TSLPR-/- mice compared to TSLPR+/+ littermate controls
(Figure 19A), these numbers did not reach statistical significance (p > 0.1) due to
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variability within groups and limited cell recovery from the lamina propria.

Although

preliminary in nature, these results indicate that in the steady state TSLP-TSLPR
interactions may be playing a role in limiting frequencies of CD4+ IFN-γ+ T cells in the
GALT. Frequencies of CD4+ IL-17A+ positive T cells in the GALT were also examined
and revealed a slight trend towards increased frequencies of CD4+ IL-17A+ T cells in
TSLPR-/- mice in the MLN, CP, and PP (Figure 19B). However, these differences did not
reach statistical signficance (p > 0.1) in any of the three experiments performed.
Additionally, no differences were detected between TSLPR+/+ and TSLPR-/- mice in either
the IEL or LPL compartments of the large intestine (Figure 19B).

As dysregulation of IFN-γ could be due to either alteration or impairment of other
regulatory mechanisms known to be important in the intestine, we also examined the
frequency of CD4+ IL-10+ and CD4+ FoxP3+ T cells in the GALT of naïve mice. We
observed no significant differences in the frequency of CD4+ IL-10+ T cells in TSLPR-/mice compared to TSLPR+/+ littermate controls in the MLN, CP, PP, or the IEL or LPL
compartments of the large intestine (Figure 20A).

Further, examination of the

frequencies of CD4+ FoxP3+ T cells in GALT did not reveal any consistent decreases in
the TSLPR-/- mice in comparison to littermate control TSLPR+/+ mice. (Figure 20B).
Despite the preliminary nature of this work, these findings indicate that the dysregulation
of proinflammatory cytokines was not due to an absence of CD4+ FoxP3+ or CD4+ IL-10+
cells. While TSLPR-/- mice do not develop spontaneous colitis, these data suggest that
even in the steady state, TSLP-TSLPR interactions may play a role in the limitation of
proinflammatory cytokine production in the intestine.
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Figure 19 Naïve TSLPR-/- have increased frequencies of CD4+ IFN-γ + T cells in the
GALT

Figure 19. Naïve TSLPR-/- mice have increased frequencies of CD4+ IFN-γ+ and
CD4+IL-17A+ cells in the GALT compared to naïve littermate control TSLPR+/+
mice. Cells were isolated from the mesenteric lymph node (MLN), cecal patch
(CP), peyer’s patch (PP), large intestine intraepithelial lymphoid cells (LI IEL),
large intestine lamina propria (LI LPL), and are gated on viable, CD3+, CD4+. (A)
IFN-γ. (B) IL-17A. Numbers are average of CD3+ CD4+ cytokine+ cells from two
mice per group and are representative of three independent experiments with 2-4
mice per group.
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Figure 20 Frequencies of GALT CD4+ IL-10+ and CD4+ FoxP3+ T cells in naïve
TSLPR-/- mice

Figure 20. Frequencies of CD4+ IL-10+ and CD4+ FoxP3+ cells in the GALT of
naïve TSLPR+/+ mice. Cells were isolated from the mesenteric lymph node (MLN),
cecal patch (CP), peyer’s patch (PP), large intestine intraepithelial lymphoid cells
(LI IEL), large intestine lamina propria (LI LPL), and are gated on viable, CD3+,
CD4+. (A) IL-10. (B) FoxP3. Numbers are average of CD3+ CD4+ cytokine+ cells
from two mice per group and are representative of two independent experiments
with 2-4 mice per group.
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rTSLP treatment of whole splenocyte cultures results in decreased frequencies of
CD4+ IFN-γ + T cells
The increased frequencies of CD4+ IFN-γ+ T cells in the GALT of naïve TSLPR-/- mice
suggests that TSLP maybe regulating CD4+ T cell production of IFN-γ. However, as the
mice utilized in those experiments have a germ-line deletion of TSLPR, the findings may
be confounded by developmental defects. In order to rule out the possibility of any
confounding developmental defects, an in vitro culture system utilizing WT mice was
employed.

Splenocytes from WT C57/BL6 mice were cultured for three days in the

presence or absence of rTSLP. Cells were cultured with soluble α-CD3/α-CD28 and
either α-IL-4/α-IFN-γ to stimulate under neutral conditions or α-IL-4/rIL-12 for TH1
permissive conditions. Under neutral conditions, the addition of rTSLP decreased the
frequency of CD4+ IFN-γ+ T cells by a third compared to the untreated control (Figure
21A). Examination of the MFI of the IFN-γ+ cells also revealed a decrease with rTSLP
supplementation, indicating that the cells treated with rTSLP were producing less
cytokine on a per cell basis compared to cells in the control wells (Figure 21A). rTSLP
treatment in the TH1 permissive conditions also resulted in a decrease in both the
frequency of CD4+ IFN-γ+ cells and the MFI of cytokine positive cells (Figure 21A).
However, the inhibition of IFN-γ was not as striking as that seen in the neutral conditions.
In order to ascertain if rTSLP had an impact on IFN-γ protein production under TH1
polarizing conditions, cell free supernatants were harvested and analyzed by ELISA.
Treatment with rTSLP significantly decreased the amount of IFN-γ protein secreted into
the supernatants (Figure 21B), indicating that rTSLP was able to substantially inhibit
IFN-γ production under TH1 permissive conditions. It remains possible that the inhibition
of IFN-γ was a secondary result of TSLP’s known ability to drive IL-4 production, which is
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well known to counter-regulate CD4+ T cell production of IFN-γ. However, the inhibition
of IFN-γ occurred in the presence of IL-4 neutralizing mAb in both neutral and TH1
permissive conditions, indicating another mechanism of action. Taken together with our
in vivo findings, these results indicate that rTSLP is able to modulate IFN-γ production by
CD4+ T cells.
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Figure 21 Treatment of splenocyte cultures with rTSLP inhibits IFN-γ production

Figure 21. Administration of rTSLP inhibits CD4+ IFN-γ production. Whole
splenocytes were cultured with soluble αCD3/αCD28, rTSLP was supplemented
daily at a concentration of 50 ng/ml. (A) Intracellular cytokine staining of cells
harvested at day 3. Horizontal numbers indicate frequency of IFN-γ+CD4+ T cells,
vertical numbers indicated MFI of IFN-γ+ cells. (B) Cell free supernatants of the
TH1 polarizing conditions were assayed by ELISA for IFN-γ. Error bars indicate
s.e.m. Data is representative of two independent experiments.
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TSLP regulates DC production of IL-12/23p40 both in vitro and in vivo
The dysregulation of CD4+ T cell production of IFN-γ observed in the GALT of TSLPR-/mice both in the steady state and following Trichuris infection suggests a possible
alteration in signals that influence T helper cell differentiation.

As previous in vitro

studies demonstrated that TSLP could inhibit IL-12 secretion from human DCs (AlShami, Spolski et al. 2005; Ito, Wang et al. 2005; Rimoldi, Chieppa et al. 2005), we next
wanted to investigate whether dysregulated IL-12/23p40 production could be playing a
role early following infection. Analysis of CD11c+ CD11b+ DCs isolated from MLNs of
infected TSLPR-/- mice showed increased production of the proinflammatory cytokines
TNF-α and IL-12/23p40 at day 10 post-infection (Figure 22 A, B). Additionally, levels of
IL-12/23p40 mRNA were increased in the large intestine of TSLPR-/- mice at day 12
post-infection (Figure 22C). These data demonstrate an in vivo role for TSLP in the
regulation of infection-induced IL-12/23p40 production from intestinal DCs.

To examine the ability of IEC-derived TSLP to modulate DC function, an in vitro
conditioning system was employed. Bone marrow-derived DCs (BMDCs) were cultured
overnight in the presence of supernatants taken from the IEC line CMT-93 (IEC-Sup),
which is known to express TSLP (Zaph, Troy et al. 2007). Control and conditioned
BMDCs were subsequently stimulated with LPS for 8 hours. Exposure to IEC-Sup did
not impair the ability of DCs to respond to LPS as IEC-Sup-conditioned BMDCs
exhibited normal upregulation of surface expression of MHC Class II and the
costimulatory molecules CD80 and CD86 as compared to unconditioned BMDCs (Figure
22D). Further, conditioning with IEC-Sup did not alter or inhibit LPS-induced production
of TNF-α (Figure 22 E, G).

However, IEC-Sup-conditioned DCs exhibited reduced
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production of IL-12/23p40 (Figure 22 F, H).

As the IEC-Sup contains multiple IEC-

derived factors, we sought to determine the contribution of TSLP to the regulation of DC
responses by utilizing recombinant TSLP (rTSLP). Similar to the results with IEC-Sup,
exposure of BMDCs to rTSLP did not alter their surface marker expression or production
of TNF-α following LPS stimulation but did result in decreased IL-12/23p40 production in
comparison to control treated BMDCs (Figure 22 I-K). These findings demonstrate the
ability of TSLP to selectively regulate DC production of IL-12/23p40. Consistent with
their inhibition of IL-12/23p40, both IEC-Sup- and rTSLP-conditioned BMDCs induced
fewer CD4+ T cells to produce IFN-γ in antigen specific co-culture assays (Figure 22L).
Taken as a whole, these results indicate that TSLP is important in the regulation of DCderived IL-12/23p40 both in vitro and in vivo.
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Figure 22 TSLP regulates DC production of IL-12/23p40 in vitro and in vivo
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Figure 22 TSLP regulates DC production of IL-12/23p40 in vitro and in vivo

Figure 22. TSLP inhibits DC production of IL-12/23p40 in vivo and in vitro. (A-B)
TSLPR-/- mice have increased DC-derived proinflammatory cytokine production at
day 10 post-infection. Cells were isolated from MLN and restimulated directly ex
vivo with Trichuris ES antigen. Cells are gated on CD11c+ CD11b+ populations.
(A) TNF-α, (B) IL-12/23p40. (C) IL-12/23p40 mRNA expression in the colon at day
12 post-infection. (D-F) Supernatants from the IEC CMT-93 cell line specifically
inhibit LPS-induced IL-12/23p40 production. (D) LPS-induced upregulation of
MHC-II, CD80, and CD86. (E-F) BMDC cytokine production was measured using
intracellular cytokine staining (ICS). (E) TNF-α, (F) IL-12/23p40. (G-H) Cytokine
secretion was assayed by ELISA of the supernatants. (G) TNF-α, (H) IL12/23p40. (I-J) rTSLP specifically inhibits LPS-induced IL-12/23p40 production.
(I) LPS-induced upregulation of MHC-II, CD80, and CD86. (J-K) BMDC cytokine
production as measured using ICS, (J) TNF-α, (K) IL-12/23p40. (L) IEC and
rTSLP conditioning of BMDCs decreased CD4+ T cell production of IFN-γ upon coculture. Error bars indicate s.e.m. A-C represent two individual experiments with
3 mice per group. D-K represent three to five individual experiments, L two
individual experiments.
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TSLPR-/- mice exhibit an increased susceptibility to DSS-induced colitis
The dysregulation of DC-derived IL-12/23p40 and CD4+ IFN-γ+ T cells in the intestine
observed in the TSLPR-/- under both homeostatic and infection-induced settings
suggests that TSLPR-/- mice may be predisposed to the development of severe intestinal
inflammation following intestinal damage.

To assess whether the ability of TSLP to

influence intestinal proinflammatory cytokine extended beyond helminth infection, we
utilized the dextran sodium sulfate (DSS) model of chemical-induced colitis.

Oral

administration of DSS is toxic to IECs and induces IEC damage, barrier leakage and
exposure of sub-epithelial immune cells to commensal bacteria.

Barrier breakdown

results in immune cell recruitment, increased expression of proinflammatory cytokines,
and the development of focal ulcerations in the large intestine (Byrne and Viney 2006).

WT and TSLPR-/- mice were exposed to 5% DSS in their drinking water for four days and
disease was assessed daily. DSS-treated TSLPR-/- mice exhibited more rapid weight
loss in comparison to treated WT mice, displaying weight loss as early as day 1 posttreatment (Figure 23A). Increased weight loss in the TSLPR-/- mice correlated with early
disease onset and increased disease severity as measured by fecal consistency, rectal
bleeding, and general appearance as well as weight loss (Figure 23B). At day four postDSS treatment, sections from the mid colon of DSS-treated WT mice revealed mild
thickening of the muscularis and minimal presence inflammatory cells.

In contrast,

tissue sections from DSS-treated TSLPR-/- mice exhibited severe thickening of the
muscularis, a marked mucosal inflammatory cell infiltrate, and large numbers of focal
lesions characterized by epithelial cell sloughing, increased inflammatory cell infiltrate
and loss of crypt architecture (Figure 23C). Consistent with the increased severity of
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disease score and inflammation, direct ex vivo organ culture of colonic segments
displayed increased production of IL-12/23p40 in the DSS-treated TSLPR-/- mice (WT
0.18 ± 0.05 ng/ml/mg tissue; TSLPR-/- 0.33 ± .08 ng/ml/mg tissue). Ex vivo analysis of
MLN cells from day four post-DSS treatment demonstrated an increased number of IFNγ+ CD4+ T cells in DSS-treated TSLPR-/- mice compared to WT DSS-treated mice (Figure
23D). In addition, polyclonal restimulations of MLN cells harvested at day four post-DSS
treated TSLPR-/- mice revealed increased levels of IFN-γ in comparison to DSS-treated
WT mice (Figure 23E). DSS-treated TSLPR-/- mice also displayed exacerbated colonic
shortening, thickening, and enteric bleeding at day 6 post treatment compared to DSStreated WT mice (Figure 23 F, G). Collectively, these results demonstrate a previously
unrecognized role for TSLP-TSLPR interactions in the regulation of intestinal
inflammation in a murine model of IBD.
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Figure 23 TSLPR-/- mice exhibit an increased susceptibility to DSS colitis

Figure 23. TSLP-TSLPR interactions limit proinflammatory cytokine production and
inflammation in DSS colitis. (A) Weight loss. (B) Total pathology score for WT and
TSLPR-/- mice on 5% DSS. (C) Paraffin-embedded cecal sections from day 4
post-DSS administration were stained with H&E. Bar, 50 µm. (D) Total number of
CD4+ IFN-γ+ T cells isolated from the MLN at day 4 post-DSS. (E) Cytokine
production from anti-CD3 anti-CD28 restimulated MLN cells was determined by
ELISA. (F) Colon of day 6 DSS-treated WT and TSLPR-/- mice, Bar, 1 cm. (G)
Colonic shortening, data are presented as percent length of naïve. Error bars
indicate s.e.m. * p ≤ 0.05 ** p ≤ 0.08Data are representative of three individual
experiments with 4-5 mice per group.
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Discussion
Results presented in this chapter highlight a previously unrecognized role for TSLPTSLPR interactions in the regulation of proinflammatory cytokine production and
inflammation within the intestine. Though TSLPR-/- mice do not develop spontaneous
colitis, analysis of GALT tissues from naïve TSLPR-/- mice revealed dysregulated DCderived IL-12/23p40 production as well as increased frequencies of CD4+ IFN-γ+ T cells,
indicating dysregulated intestinal immune homeostasis.

The role of TSLP in this

dysregulation was confirmed as in vitro addition of rTSLP into splenocyte cultures
resulted in the inhibition of CD4+ T cell IFN-γ production. Further, TSLP was shown to
modulate DC-derived IL-12/23p40 both in vitro and in vivo. The disruption in intestinal
immune homeostasis in the absence of TSLP-TSLPR interactions has a functional
consequence, as TSLPR-/- mice exhibited an increased susceptibility to DSS-induced
colitis.

TSLPR-/- mice displayed increased disease pathology, inflammatory cytokine

production, and more severe intestinal inflammation compared to DSS-treated WT
control animals. Taken together, these findings suggest that in addition to promoting
TH2 cytokine responses, a function of TSLP in the intestinal microenvironment may be to
directly and/or indirectly inhibit proinflammatory cytokine production.

Although these data extend the function of TSLP beyond its well-established role in
directly promoting TH2 cytokine responses, the ability of TSLP to modulate
proinflammatory cytokine production has been previously indicated.

In vitro studies

showed TSLP-treated DCs exhibit reduced production of IL-12/23p40 upon TLR ligation,
and the ability of DC-derived OX40L to drive TH2 cell differentiation is critically
dependent upon the absence of IL-12 (Soumelis, Reche et al. 2002; Ito, Wang et al.
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2005; Rimoldi, Chieppa et al. 2005; Zaph, Troy et al. 2007). In addition, transgenic overexpression of TSLP in the skin decreased the frequency of CD4+ IFN-γ+ T cells in the
transgenic mice in comparison to normal littermate controls, and TSLPR-/- mice exhibited
significantly increased IL-12 mRNA levels in the lungs compared to WT animals
following OVA-induced allergic inflammation (Al-Shami, Spolski et al. 2005; Yoo, Omori
et al. 2005). These findings are consistent with a role for TSLP in negatively regulating
proinflammatory cytokine production in DC populations in peripheral sites.

Thus the

exaggerated TH2 cytokine-mediated diseases in mice with transgenic over-expression of
TSLP may be a result of simultaneous increases in TH2 cytokine responses and
decreased expression of proinflammatory cytokines including IL-12 and IFN-γ that would
counter-regulate developing TH2 cytokine responses.

While our results highlight the ability of TSLP to modulate proinflammatory cytokine
production in the intestine, the exact mechanisms of action and molecular pathways
involved remain unclear. As TSLPR is functionally expressed on a variety of cell types
including DCs, mast cells, basophils, and CD4+ T cells (see Chapter 2), it is not known if
TSLP is acting either directly, or indirectly to modulate CD4+ T cell IFN-γ production.
TSLP may be acting indirectly through DCs, as TSLP-treatment of DCs inhibits IL12/23p40 production in a manner that results in decreased production of IFN-γ from cocultured CD4+ T cells (Figure 23L). Although the ability of TSLP to inhibit DC production
of IL-12/23p40 has been well documented (Soumelis, Reche et al. 2002; Ito, Wang et al.
2005; Rimoldi, Chieppa et al. 2005; Zaph, Troy et al. 2007), the signaling pathways
induced by TSLP in DCs to regulate gene expression are unknown at present.
Additionally, TSLP treatment of DCs may influence intestinal cytokine production by
121

altering the composition of immune cell populations within the intestine.

As TSLP-

treatment of DCs is known to induce expression of the TH2 cell-attracting chemokine
CCL20, and the T cell-attracting chemokine CCL17 (Reche, Soumelis et al. 2001;
Soumelis, Reche et al. 2002), TSLP could be increasing the recruitment of non-IFN-γ
producing T cells to the intestine.

TSLP may also act directly on CD4+ T cells to limit TH1 cell differentiation. Although
rTSLP was shown to inhibit CD4+ T cell production of IFN-γ in the absence of IL-4
(Figure 21), it remains possible that TSLP is regulating IFN-γ production through its
promotion of TH2 cytokine responses. TSLP is known to promote expression of GATA-3
and IL-4 in CD4+ T cells (Omori and Ziegler 2007); pathways that inhibit expression of
IFN-γ (Murphy and Reiner 2002; Szabo, Sullivan et al. 2003). Direct inhibition of CD4+ T
cell IFN-γ production may also be possible.

For instance, TSLP activates STAT5

(Isaksen, Baumann et al. 1999; Levin, Koelling et al. 1999), and STAT5a activation in
CD4+ T cells has been shown to inhibit IL-12-induced STAT4 activation through the
induction of SOCS3 (Takatori, Nakajima et al. 2005). However, it remains unknown
which of these pathways, if any, contribute to the ability of TSLP to decrease CD4+ T cell
production of IFN-γ.

TSLP may also act indirectly through innate cell production of IL-4 to influence CD4+ T
cell production of IFN-γ. In conjunction with other cytokines, TSLP has been shown to
induce mast cell production of TH2 cytokines (Soumelis, Reche et al. 2002; Allakhverdi,
Comeau et al. 2007; Allakhverdi, Smith et al. 2007; Okayama, Okumura et al. 2009),
indicating mast cells could represent an important source of IL-4. However, as mast
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cells are not normally present within the GALT at high frequencies, and TSLP-induced
TH2 cytokine production requires the presence of additional cytokines, it is possible that
mast cell-derived IL-4 plays a more important role in the inhibition of CD4+ T cell IFN-γ
production under situations of inflammation or infection. Further studies must be done to
determine the relative importance of TSLP acting either indirectly through DCs and/or
mast cells, or directly through CD4+ T cells, to inhibit CD4+ T cell production of IFN-γ. It
is important to note that these possibilities are not mutually exclusive and that it is
feasible that TSLP is utilizing multiple mechanisms to limit proinflammatory cytokine
production and inflammation in the intestine.
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CHAPTER 5: Discussion and Future Directions

Introduction
It has been fifteen years since the biological activity of TSLP was first described (Friend,
Hosier et al. 1994) and ten years since the genes for both TSLP and TSLPR were
cloned and sequenced (Park, Martin et al. 2000; Sims, Williams et al. 2000; Quentmeier,
Drexler et al. 2001). Despite numerous and significant advances in understanding the
role of TSLP in lymphoid development and in the promotion of TH2 cytokine-mediated
inflammation in the skin and the lung (see Chapter 1), the understanding of the role of
TSLP in the intestinal immune system is still in its infancy. While expression of TSLP
mRNA was noted in the ileum of the small intestine in 2000 (Sims, Williams et al. 2000),
a function for TSLP in the intestine was not proposed until 2005 when Rescigno and
colleagues demonstrated that TSLP was important in maintaining intestinal immune
hyporesponsiveness through the promotion of TH2 cell differentiation (Rimoldi, Chieppa
et al. 2005).

Despite advances in identifying both TSLP-expressing and TSLP-

responsive cell populations in vitro, the relevant cellular sources and targets of TSLP in
vivo remain largely unknown. In addition to these more basic questions, the biological
function of TSLP-TSLPR interactions within the intestine has also not been fully defined.
At the onset of this thesis, it was unknown if TSLP was critically required for the
development of host-protective intestinal TH2 cytokine-mediated immune responses, or if
the function of TSLP in the intestinal microenvironment extended beyond its ability to
promote TH2 cytokine responses. Within this context, it was the goal of this thesis to
begin to define and characterize the role of TSLP-TSLPR interactions in regulating
intestinal immunity and inflammation.
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Summary, discussion, and future directions
TSLP and TSLPR complex expression in the intestine
In Chapter 2 of this thesis, in order to achieve a more comprehensive understanding of
the cellular components of TSLP-mediated regulation in the intestine, I characterized the
cellular sources and targets of TSLP in the large intestine and GALT.

Further, I

determined the functionality of TSLPR complex expression on GALT-derived CD4+ T
cells and CD11c+ DCs.

From these studies, we demonstrated that under naïve

homeostatic conditions, the dominant source of TSLP within the large intestine is IECs
(Figure 5). Further, we found that surface expression of TSLPR complex is extensive
throughout tissues of the GALT, being detected on CD11c+ DCs, CD4+ T cells, as well
as the innate cell populations of basophils and mast cells (Figures 6-8).

Also, we

demonstrated that both CD11c+ DCs and CD4+ T cells from the GALT can respond to
TSLP and upregulate phosph-STAT5 directly ex vivo without additional activation or
stimulation (Figure 9).

Regulation of TSLP expression in the intestine
The constitutive expression of TSLP from IECs in the large intestine is consistent with
previous findings (Rimoldi, Chieppa et al. 2005), however the cellular signals that
mediate or induce this expression remain unidentified.

In vitro studies have

demonstrated that TSLP production from epithelial cells can be elicited by external
factors such as TLR ligands and viruses as well as by host-derived factors such as
cytokines (Saenz, Taylor et al. 2008), making it difficult to distinguish the relevant signals
driving TSLP expression within the intestinal tract. The elevated expression of TSLP in
the large intestine compared to the small intestine or cecum correlates with the
125

increasing population size of commensal bacteria in the distal portions of the GI tract.
This makes it tempting to speculate that TSLP expression, may, at least in part, be
driven by commensal-derived signals. However, preliminary studies comparing TSLP
mRNA expression in large intestine tissue between conventionally housed mice and
germ free mice showed no significant alteration in expression between experimental
groups (Colby Zaph, personal communication, and data not shown), indicating that
commensal-derived signals may not be essential for intestinal TSLP expression. These
findings do not entirely rule out external stimuli in driving IEC TSLP expression,
however, since sterilized mouse chow has been found to contain detectable levels of
bacterial DNA (David Hill, personal communication), which could act as a stimulatory
signal for TSLP expression in germ-free mice.

Finally, it is possible that food antigens

or the mechanical act of digestion and smooth muscle contraction could stimulate TSLP
production by IECs.

In addition to externally-derived signals, host-derived cytokines could also play a role in
stimulating TSLP expression in the intestine. As the intestine is an active immunologic
site, continually being stimulated by environmental, food, and commensal bacteriaderived antigens, the steady state production of cytokines within the intestine could be
sufficient to induce TSLP expression.

Although many possible cytokine candidates

exist, TSLP was induced following Trichuris infection in SCID mice (Humphreys, Xu et
al. 2008), indicating an innate cell source.

Additionally, IECs themselves must be

considered as a source of factors that could regulate TSLP expression. It is possible
that IEC-derived products could be acting in an autocrine fashion to induce constitutive
TSLP expression. It is important to note that the possible mechanisms to stimulate IEC
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TSLP production are not mutually exclusive and that that many factors may act to
regulate expression of TSLP within the intestine.

Although IECs appear to be the main source of TSLP within the intestine, recent work
has indicated that innate cells may also represent a source of TSLP. Studies have
demonstrated that mast cells upregulate both TSLP mRNA and protein following FcεRI
cross-linking (Soumelis, Reche et al. 2002; Okayama, Okumura et al. 2009).
Additionally, basophils upregulate both TSLP mRNA and protein following stimulation
with papain (Sokol, Barton et al. 2008).

As both mast cells and basophils require

stimulation to produce TSLP (Allakhverdi, Comeau et al. 2007; Sokol, Barton et al.
2008), it remains possible that they only function as sources of TSLP in situations of
infection and/or inflammation. Also, as mast cells and basophils are normally present at
very low frequencies within the lamina propria and GALT, infection and/or inflammationderived signals may be required to recruit enough of these cells into the tissues to
become a physiologically relevant source of TSLP.

Given the recently discovered

importance of antigen presenting basophils in the initiation of TH2 cytokine immune
responses (Perrigoue, Saenz et al. 2009; Sokol, Chu et al. 2009; Yoshimoto, Yasuda et
al. 2009), it is possible that basophil-derived TSLP may play an important role in the
initiation of intestinal TH2 immune responses. However, more studies will need to be
done to determine if basophil-derived or mast cell-derived TSLP is sufficient to influence
intestinal immune responses, and if its expression can be controlled or regulated.

Cellular targets of TSLP and regulation of TSLPR expression
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Identification of the cellular targets of TSLP has been hindered by a lack of reagents that
are able to specifically and reliably detect surface protein expression of the TSLPR-α
chain of the TSLPR complex. Previous studies have largely been limited to the
examination of either TSLPR mRNA expression in whole tissues, cell lines, or in purified
populations or by in vitro binding assays (Park, Martin et al. 2000; Reche, Soumelis et al.
2001; Allakhverdi, Comeau et al. 2007). Our findings of surface expression of TSLPR-α
chain on GALT CD11c+ DCs and mast cells are consistent with the published literature
(Reche, Soumelis et al. 2001; Soumelis, Reche et al. 2002; Rimoldi, Chieppa et al.
2005; Allakhverdi, Comeau et al. 2007); however, we extended these findings by
demonstrating co-expression of the second, critically required chain of the heterodimeric
TSLPR complex, CD127 (IL-7Rα) on these cell populations (Figure 6, 7). We also show
that in addition to being cellular sources of TSLP (Sokol, Barton et al. 2008), basophils
express the TSLPR complex (Figure 6).

Our characterization of TSLPR complex

expression in the GALT also revealed functional receptor surface expression on CD4+ T
cells directly ex vivo. These findings are inconsistent with in vitro studies on human
CD4+ T cells, which showed no surface expression on freshly isolated cells (Rochman,
Watanabe et al. 2007; Lu, Wang et al. 2009). Although the source of the discrepancy is
unknown, it is possible that there is species-specific regulation of TSLPR expression.
Alternatively, the sensitivity of the reagents utilized in the studies could be different.
Nonetheless, our data showing CD4+ T cell phospho-STAT5 activation following TSLP
treatment indicate that within the murine model, the possibility of TSLP acting directly on
naïve CD4+ T cells must be taken into account.
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Although we have a basic understanding of the factors than can regulate TSLP
expression (Chapter 1), very little is known about the factors that regulate TSLPR
complex expression. On the cellular level, work focusing on human CD4+ T cells found
upregulation of the TSLPR-α chain following polyclonal activation (Rochman, Watanabe
et al. 2007; Lu, Wang et al. 2009). Studies examining TSLPR mRNA expression in
whole tissues indicate that TSLPR expression is dynamically regulated during the course
of helminth infection (Humphreys, Xu et al. 2008; Ramalingam, Pesce et al. 2009).
However, due to the nature of these studies it is not known if the regulation of TSLPR
expression was mediated directly by the pathogen, or was a result of the immune
response following infection. Our in vitro findings utilizing BMDCs suggest that both
methods of regulation may be possible as TSLPR expression was upregulated following
treatment with helminth-derived products as well as with both pro- and anti-inflammatory
cytokines (Figure 6). However, as treatment with LPS and CpG did not mediate TSLPR
upregulation in BMDCs (Figure 6) and TSLPR expression has not been examined
following infection with either bacterial or viral pathogens, it is possible that the ability of
pathogens to modulate TSLPR expression is restricted to helminths.

Treatment of

BMDCs with papain induced TSLPR upregulation, indicating that the TSLPR complex
may also be dynamically regulated in allergic responses. While these findings begin to
hint at the signaling pathways that could potentially be involved, the exact mechanisms
and mediators remain unknown, and it is unclear whether regulation of receptor
expression differs between cell types.

Future directions and challenges
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As TSLP is a relatively new cytokine, many basic and fundamental questions remain
unanswered regarding both its production and cellular targets. Much of the work done
characterizing the factors that regulate TSLP expression has been done in vitro, and the
physiologic relevance of these findings remains to be determined. Further, it is unclear
how the inherently different microenvironments of the skin, lung, and intestine influence
either epithelial or innate cell production of TSLP. Recent advances in the development
of reliable reagents to detect TSLPR-α chain surface expression have begun to allow
analysis of target cell populations directly ex vivo. Despite this, it is unknown what role,
if any, TSLPR regulation plays in modulating immune responses in vivo. Future studies
focusing on TSLP and TSLPR expression must move in vivo to extrapolate the
physiologically relevant signals that both positively and negatively regulate expression.

In addition to defining regulatory signals for both TSLP and TSLPR expression, a more
in depth understanding of the TSLP signaling pathway is needed.

The current

understanding of TSLP signaling is limited (Sebastian, Borowski et al. 2008), with the
kinases and target genes largely unresolved.

Further, the majority of the studies

examining TSLP signaling were conducted in cell lines transfected with components of
the TSLPR, or in cell types that are now known to not be physiologically relevant targets
of TSLP (Isaksen, Baumann et al. 1999; Levin, Koelling et al. 1999; Isaksen, Baumann
et al. 2002).

Thus it is difficult to ascertain the relevance of these findings and

understand how it relates to TSLP signaling in primary cells. Also, it is unknown if TSLP
signaling varies from one cell population to another, which, given the numerous
downstream functions attributed to TSLP signaling, seems likely. For instance, while
TSLP alone is sufficient to influence DC function (Reche, Soumelis et al. 2001;
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Soumelis, Reche et al. 2002), treatment with TSLP alone does not impact mast cell
function (Allakhverdi, Comeau et al. 2007).

Despite constitutive TSLPR complex

expression (Figure 7 and (Allakhverdi, Comeau et al. 2007)), mast cells require
sensitization with either IL-1, TNF-α, or IL-33 for TSLP to induce TH2 cytokine release
(Allakhverdi, Comeau et al. 2007; Allakhverdi, Smith et al. 2007).

The mechanism

behind this regulation is not clear. It is possible that the sensitization signal results in the
de-repression of TSLP signaling, or that it alters the abundance of the required
downstream signaling molecules.

Further studies must be conducted focusing on

TSLPR signaling in multiple cell types.

Although much progress has been made in understanding the functional biology of
TSLP, it remains important to address fundamental questions regarding the regulation of
both the ligand and the receptor.

Additionally, the current limitations in the

understanding of TSLP signaling make it difficult to identify and assess potential cross
regulation from other cytokines. Answering these questions will be key to understanding
the biology of TSLP in the intestine as well as in other tissues. Further, these findings
may help identify components of the regulatory network that could potentially be
exploited for therapeutic benefit.

The role for TSLP in intestinal TH2 cytokine-mediated immune responses
In Chapter 3, I directly tested the hypothesis that TSLP-TSLPR interactions would be
required for the development of a host-protective TH2 cytokine-mediated immune
response in the intestine utilizing infection with the model GI nematode pathogen
Trichuris. From these studies, we demonstrated that while TSLP-TSLPR interactions
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are required for immunity to Trichuris, TSLP-independent TH2 cytokine responses
developed in the absence of IFN-γ (Figure 17). These findings demonstrate that TSLP is
not critically required for the initiation of TH2 cytokine responses in the intestine.

The requirement for TSLP in infection-induced TH2 cytokine responses
Although TSLP is important in both the initiation and promotion of allergic TH2 cytokinemediated inflammation in the skin and lung (Liu 2006; Liu, Soumelis et al. 2007), our
findings indicate that TSLP is not critically required for the initiation of an infectioninduced TH2 cytokine response in the intestine (Chapter 3). While it remains possible
that tissue-specific differences exist in terms of TSLP function, more recent work
suggests that the requirement for TSLP in the initiation and promotion of TH2 cytokine
responses varies between situations of allergy and infection.

In addition to our findings, TSLP-independent intestinal TH2 cytokine responses have
also been documented in situations of infection. TSLPR-/- mice were demonstrated to
mount TH2 cytokine responses following infection with the intestinal dwelling helminth
Heligmosomoides polygyrus (H. polygyrus) (Massacand, Stettler et al. 2009). Further,
TSLPR-/- mice exhibited intact TH2 cytokine-mediated immunity to infection with
Nippostrongylus brasiliensis (N. brasiliensis), a helminth pathogen with an intestinal
phase of infection (Massacand, Stettler et al. 2009). Also, TSLP does not appear to be
required for infection-induced TH2 cytokine responses in the liver or lung.

Although

TSLPR-/- mice infected with Schistosoma mansoni (S. mansoni) cercariae exhibited
reduced production of IL-13 and decreased liver fibrosis at 9 weeks post infection
compared to WT controls, TSLPR-/- mice produced equivalent levels of IL-4 and IL-5 to
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WT mice.

Also, TSLPR-/- mice still developed chronic infection and exhibited TH2-

cytokine-dependent pathology in the liver that was indistinguishable from WT mice at 12
weeks post-infection (Ramalingam, Pesce et al. 2009). The role of TSLP in pathogeninduced airway inflammation was investigated utilizing infection with N. brasiliensis,
whose migration through the lung induces TH2 cytokine-mediated inflammation and
pathology. TSLPR-/- mice infected with N. brasiliensis not only cleared both primary and
secondary infections, but also developed TH2 cytokine responses, and TH2 cytokinedependent lung inflammation comparable to WT control mice (Massacand, Stettler et al.
2009).

Overall, these studies focusing on the role of TSLP in infection indicate that while TSLP
may be important for optimal responses, it is not strictly required for the development of
infection-induced TH2 cytokine responses. These data support the hypothesis that TSLP
is required in allergen-driven TH2 cytokine responses, but not in situations of infection.
However within the intestine, the corollary of TSLP involvement in allergen-driven
responses remains unknown. As food allergy is associated with intestinal TH2 cytokine
immune responses (Nagler-Anderson 2001; Devereux 2006), we hypothesize that TSLP
will be important in food allergen-associated immune responses.

Allergy versus infection
It remains unclear why TSLP is differentially required in situations of allergy-driven TH2
cytokine responses and infection-induced TH2 cytokine responses.

Although allergic

responses and the subsequent TH2 cytokine-mediated inflammation are pathological,
and infection-induced TH2 cytokine responses are usually host-protective, the line
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between protective and pathologic becomes blurred when examining chronic helminth
infections such as S. mansoni.

TSLPR-/- mice still develop severe TH2 cytokine-

dependent pathology in the liver following S. mansoni infection (Ramalingam, Pesce et
al. 2009). Ramalingam et al. propose that the different routes of Ag exposure may be
sufficient to explain the difference between the requirement for TSLP in allergy and
infection.

As opposed to allergens, which primarily interact with epithelial cells at

mucosal surfaces, helminth infection usually results in Ag exposure in and damage to
multiple tissues as a result of parasite migration and maturation. It is possible therefore,
that the increased damage and more systemic level of stimulation triggers other TH2
cytokine-inducing factors, alleviating the need for TSLP (Ramalingam, Pesce et al.
2009).

This hypothesis of altered route of Ag exposure and increased tissue damage is also
consistent with the observed differences in the requirement for TSLP in TH2 cytokine
responses between infection with H. polygyrus and Trichuris. TSLP is not required for
the generation of a TH2 cytokine response to infection with H. polygyrus (Massacand,
Stettler et al. 2009), whose life cycle requires penetration of the intestinal submucosa
and migration through intestinal muscle tissue (Finkelman, Shea-Donohue et al. 1997).
In contrast, TSLP is required for TH2 cytokine-mediated immunity to Trichuris (Chapter 3,
(Massacand, Stettler et al. 2009), whose life cycle is entirely enteric, with worms only
embedding their anterior ends within the epithelial cell layer of the intestine, never
penetrating the submucosa or the muscle (Cliffe and Grencis 2004). Thus, it is possible
that TSLP is required in response to Trichuris infection because the life cycle of the
worm does cause sufficient tissue damage or Ag exposure outside of the intestinal
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epithelium to trigger other TH2 inducing factors. Although more work needs to be done
to determine the reason for the differential requirement of TSLP in allergen-induced and
infection-induced TH2 cytokine responses, it is possible that signals derived from
infection-induced tissue damage may play a role.

The functional biology of TSLP in Trichuris infection
The demonstration that TSLPR-/- mice are capable of mounting TH2 cytokine responses
to N. brasiliensis and H. polygyrus raises the question about the differential requirement
for TSLP in Trichuris infection. As TSLP is not required for the initiation of TH2 cytokine
responses in other intestinal infections (Massacand, Stettler et al. 2009), it must serve
another function during Trichuris infection important in the creation of a TH2 permissive
microenvironment. Work from Massacand et al. pinpoints the importance of TSLP in the
inhibition of DC-derived IL-12/23p40 in Trichuris infection. While ES products from N.
brasiliensis and H. polygyrus inhibit BMDC production of IL-12/23p40, ES products from
Trichuris fail to block DC-derived IL-12/23p40 in vitro. Blockade of IL-12/23p40 in vivo
during Trichuris infection is sufficient to restore immunity to TSLPR-/- mice (Massacand,
Stettler et al. 2009).

Taken together with our findings, these data suggest that primary function of TSLP in
Trichuris infection is to inhibit proinflammatory cytokine production, as TSLPindependent mechanisms are sufficient to drive TH2 cytokine responses in the absence
of the TH1-associated cytokine IL-12/23p40 and IFN-γ.

Thus, in comparison to N.

brasiliensis and H. polygyrus, Trichuris lacks the ability to modulate the intestinal
immune response, and requires TSLP to take the place of a pathogen-derived factor to
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Although TSLP is not required for the development of protective immunity to Trichuris in
the absence of proinflammatory cytokines, the relevant cellular sources and targets of
TSLP during infection remain undefined.

Though IECs appear to be the dominant

source of TSLP in the intestine, basophil and mast cell production of TSLP have been
reported (Sokol, Barton et al. 2008; Okayama, Okumura et al. 2009). As discussed
previously, it is possible that basophils and mast cells could be physiologically relevant
sources of TSLP over the course on an infection.

To address this issue, chimeric

studies must be carried out to delineate the importance of haematopoietic versus nonhaematopoietic cell expression of TSLP in vivo. Further, as previous work has been
completed with germ line knockouts of TSLPR, we do not know the function or relative
importance of TSLP acting on individual cell populations in vivo. While the studies from
Massacand et al. indicate that DCs are the pertinent target cell population in Trichuris
infection (Massacand, Stettler et al. 2009), our studies indicate that CD4+ T cells also
express functional TSLPR complex (Figure 6) and could represent an additional cellular
target, either for the inhibition of proinflammatory cytokine production (Figures 13, 16,
19), or for the initiation of TH2 cytokine production (Omori and Ziegler 2007). To address
whether CD4+ T cell restricted or accessory cell restricted TSLPR expression is sufficient
to promote a TH2 cytokine response to Trichuris, transfer studies isolating TSLPR
expression on CD4+ T cells or accessory cells need to be carried out. Understanding of
the relative contribution and importance of TSLP signaling on each cell type in vivo is
important in understanding the complexity of the functional biology of TSLP.
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Future directions and challenges
The finding of TSLP-independent infection-induced TH2 cytokine responses suggests
that the concept that TSLP plays a central role in all TH2 cytokine responses (Liu,
Soumelis et al. 2007) must be reevaluated.

The demonstration of a differential

requirement for TSLP in the initiation of allergen versus infection-induced TH2 cytokine
response indicates that the functional biology of TSLP varies dependent on the
immunological context. The fundamental differences between situations of allergy and
infection that influence the requirement for TSLP in the initiation of TH2 cytokine
responses remain to be elucidated.

Studies examining increased routes of allergen

exposure and coupling allergen exposure with tissue damage must be done to dissect
the importance of increased Ag exposure or infection-induced tissue damage in the
TSLP independence of infection-induced TH2 cytokine responses (Ramalingam, Pesce
et al. 2009) these factors. Additionally, to examine the possibility that tissue-specific
factors can influence the requirement for TSLP in allergic responses, the role of TSLP in
food allergy must be investigated. Although we hypothesize that TSLP will be required
for the generation of a food allergen-induced TH2 cytokine response, the distinct
microenvironment of the intestine may be able to compensate for the loss of TSLP,
resulting in a TSLP-independent TH2 cytokine response.
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In Chapter 4 I investigated the hypothesis that TSLP was important in the regulation of
proinflammatory cytokine production and inflammation within the intestine. Consistent
with this, naïve TSLPR-/- mice were found to have dysregulated production of DCderived IL-12/23p40 and CD4+ T cell derived IFN-γ in the GALT (Figures 19, 21).
Further, in vitro studies indicate that TSLP maintains the ability to regulate CD4+ T cell
IFN-γ production in the absence of IL-4 (Figure 20). While it is not clear whether TSLP is
acting solely through DCs to modulate CD4+ T cell IFN-γ production, TSLP regulates
DC-derived IL-12/23p40 both in vitro and in vivo (Figure 22). Although the dysregulation
of proinflammatory cytokines in the GALT does not lead to spontaneous colitis, TSLPR-/mice display an increased susceptibility to DSS-induced colitis, exhibiting increased
proinflammatory cytokine production and more severe intestinal inflammation compared
to WT control mice (Figure 23).

TSLP and the regulation of epithelial cell barrier function
Recent evidence suggests that TSLP could contribute to the regulation of intestinal
inflammation by impacting barrier function.

In vitro studies utilizing human nasal

epithelial cells (HNECs), found that TSLP treatment upregulated the tight junction
proteins claudin-1, -4, -7, and occludin within 6 -24 hours. Further, TSLP treatment
impacted barrier function as TSLP-treated HNECs showed significantly increased
transepithelial electrical resistance (TER), and decreased permeability of larger
molecular weight molecules (Kamekura, Kojima et al. 2009). As TSLPR-α chain was not
found to be expressed on HNECs or human nasal mucosa in vivo (Kamekura, Kojima et
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al. 2009), the changes in barrier permeability most likely did not result from TSLPTSLPR signaling on the epithelial cells. However, these findings still indicate that TSLP
can influence epithelial cell barrier function through an unknown mechanism.

It is possible that TSLP-mediated regulation of barrier function extends into the intestine,
and that TSLP may play an important role in barrier maintenance. Crohn’s disease is
characterized by compromised barrier function and the development of immune
responses directed against commensal bacteria (Xavier and Podolsky 2007).
Interestingly, loss of TSLP expression is observed in intestinal biopsies from Crohn’s
disease patients (Rimoldi, Chieppa et al. 2005). It remains possible that the loss of
TSLP expression observed in Crohn’s disease could contribute to the increased barrier
permeability and bacterial translocation that results in immune cell activation and
inflammation.

TSLP in the maintenance of immune homeostasis
Our findings of dysregulated intestinal proinflammatory cytokine production in the
absence of TSLPR are consistent with work from Rescigno and colleagues which
identified a role for TSLP in the maintenance of intestinal immune homeostasis (Rimoldi,
Chieppa et al. 2005). As the intestinal microenvironment is constantly being
immunologically stimulated by both food-derived and commensal bacteria-derived
antigens (Chapter 1), TSLP may have developed as a regulatory mechanism to prevent
the development of inflammation resultant from continual stimulation. However, the lack
of spontaneous colitis in TSLPR-/- mice indicates TSLP is not as central to maintaining
intestinal homeostasis as IL-10, whose deletion results in spontaneous disease (Strober,
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Fuss et al. 2002; Elson, Konrad et al. 2004). Instead, TSLP in the intestine may be one
of the many partially redundant immunoregulatory factors that act to maintain
hyporesponsiveness and homeostasis.

Currently, it remains undetermined if the ability of TSLP to regulate proinflammatory
cytokine production extends beyond the intestine to include other tissues. While there
have been indications of TSLP-mediated regulation of proinflammatory cytokine
production in both the skin and the lung (Al-Shami, Spolski et al. 2005; Yoo, Omori et al.
2005), the anti-inflammatory role of TSLP in these tissues has not yet been directly
examined. As the level of antigenic stimulation and burden of commensal bacteria is
substantially reduced in the skin and the lung, TSLP may not be required for, or
important in, the maintenance of immune cell homeostasis in these tissues.

The increased susceptibility of TSLPR-/- mice to DSS-induced colitis suggests that
TSLPR-/- mice may also have heightened TH1 cytokine responses, possibly increasing
their resistance to bacterial or viral pathogens. The immunobiology of TSLP in intestinal
infections that require TH1 cytokine responses for immunity such as Salmonella
(Monack, Mueller et al. 2004; Coburn, Grassl et al. 2007) remains unknown.

Our

findings suggest that TSLPR-/- mice would be predisposed to intestinal CD4+ T cell IFN-γ
production upon infection, possibly increasing resistance and resulting in a faster kinetic
of bacterial clearance. However, it is also possible that the predisposition and increased
IFN-γ response may lead to unregulated immune-mediated pathologies and death of the
TSLPR-/- mice. It will also be important to determine if TSLPR-/- mice have systemically
dysregulated TH1 cytokine responses.

Studies with TH1 cytokine-inducing parasitic
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infection models such as Leishmania major, which can be localized to the footpad or ear,
or intraperitoneally injected Toxoplasma gondii which results in systemic infection, have
also not been done.

Understanding the role of TSLP in TH1 cytokine responses is

important as it might impact susceptibility or resistance to infection in human diseases
where TSLP expression is dysregulated, such as Crohn’s disease (Rimoldi, Chieppa et
al. 2005) or asthma (Ying, O'Connor et al. 2005).

Future directions and challenges
Taken together, our studies suggest an important role for TSLP in the regulation of
intestinal inflammation. However, as the majority of studies completed on TSLP to date
focus on the TH2 promoting functions of TSLP, many basic questions concerning TSLPmediated regulation of proinflammatory cytokine production remain unanswered. The
mechanisms and molecular mediators involved remain undefined, and it is unclear
whether the mechanisms very between homeostatic conditions and situations of
infection or inflammation.

Understanding whether TSLP’s ability to inhibit proinflammatory cytokine production is a
tissue-specific function restricted to the intestine is of critical importance if the TSLPTSLPR pathway is to be manipulated for therapeutic benefit.

While studies have

indicated a therapeutic benefit to blocking either TSLP (Miyata, Nakamura et al. 2009) or
OX40-OX40L interactions (Seshasayee, Lee et al. 2007; Wang and Liu 2007) in
situations of atopy, our findings indicate that systemic targeting of TSLP may lead to a
predisposition to develop inflammation within the intestine. The potential for negative
consequences resulting from systemic targeting of the TSLP-TSLPR pathway highlight
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the importance of fully characterizing the functionality of TSLP in each tissue. Although
TSLP appears to be predominately associated with pathologic TH2 cytokine responses in
the skin and lung, the possible immunoregulatory function of TSLP in these tissues must
not be discounted.

Concluding remarks
The results presented in this thesis provide new insights into the role that TSLP-TSLPR
interactions play in regulating immunity and inflammation within the GI tract (summarized
in Figure 24). Data presented in Chapter 2 reveal the complex nature of TSLP-TSLPR
interactions within the intestine, as cells of both the innate and adaptive immune system
express the TSLPR complex and respond to TSLP stimulation.

In Chapter 3 we

investigate the functional biology of TSLP in intestinal infection and identify TSLPindependent host-protective TH2 cytokine responses, demonstrating that TSLP is not the
critical factor required for the initiation of TH2 immune responses.

The potential

regulatory function of TSLP is explored in Chapter 4. We demonstrate that TSLP is
important in the maintenance of intestinal immune homeostasis and can regulate
proinflammatory cytokine production in vitro and in vivo.

Collectively these studies

identify an important role for TSLP-TSLPR interactions in the regulation of the intestinal
immune system and provide insights into how this pathway could be manipulated for
therapeutic benefit when the balance of immunity and inflammation in the intestine is
disrupted.
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Figure 24 TSLP is a central regulator of intestinal immune homeostasis
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Figure 24 TSLP as a central regulator of intestinal immune homeostasis
Figure 24 TSLP-TSLPR interactions are important in the maintenance of intestinal
immune homeostasis. TSLP is produced by IECs and acts on DCs to promote TH2
cell differentiation and inhibit TH1 cell differentiation, partially through the inhibition
of DC-derived IL-12/23p40. TSLP acts directly on naïve CD4+ T cells to promote
TH2 cell differentiation and potentially inhibit IFN-γ production. TSLP acts on mast
cells in conjunction with other cytokines to induce TH2 cytokine release. Treatment
with TSLP elicits increased frequencies of basophils which act on naïve CD4+ T
cells to promote TH2 cell differentiation. Mast cells and basophils produce TSLP
following stimulation. TSLP may also act on IECs to promote barrier function.
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